p38	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
mediates	O
signal	O
integration	O
of	O
TCR	B-protein
/CD28	B-protein
costimulation	O
in	O
primary	B-cell_type
murine	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Optimal	O
T	O
cell	O
activation	O
requires	O
two	O
signals	O
,	O
one	O
generated	O
by	O
TCR	B-protein
and	O
another	O
by	O
the	O
CD28	B-protein
costimulatory	I-protein
receptor	I-protein
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
regulation	O
of	O
costimulation-induced	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
activation	O
in	O
primary	B-cell_type
mouse	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
to	O
that	O
reported	O
for	O
human	B-cell_type
Jurkat	I-cell_type
T	I-cell_type
cells	I-cell_type
,	O
we	O
found	O
that	O
p38	B-protein
MAPK	I-protein
,	O
but	O
not	O
Jun	B-protein
NH2-terminal	I-protein
kinase	I-protein
(	O
JNK	B-protein
)	O
,	O
is	O
weakly	O
activated	O
upon	O
stimulation	O
with	O
either	O
anti-CD3	B-protein
or	O
anti-CD28	B-protein
in	O
murine	B-cell_type
thymocytes	I-cell_type
and	O
splenic	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

However	O
,	O
p38	B-protein
MAPK	I-protein
is	O
activated	O
strongly	O
and	O
synergistically	O
by	O
either	O
CD3/CD28	B-protein
coligation	O
or	O
PMA/Ca2+	O
ionophore	O
stimulation	O
,	O
which	O
mimics	O
TCR	B-protein
-	O
CD3/CD28	B-protein
-mediated	O
signaling	O
.	O

Activation	O
of	O
p38	B-protein
MAPK	I-protein
correlates	O
closely	O
with	O
the	O
stimulation	O
of	O
T	O
cell	O
proliferation	O
.	O

In	O
contrast	O
,	O
PMA-induced	O
JNK	B-protein
activation	O
is	O
inhibited	O
by	O
Ca2+	O
ionophore	O
.	O

T	O
cell	O
proliferation	O
and	O
production	O
of	O
IL-2	B-protein
,	O
IL-4	B-protein
,	O
and	O
IFN-gamma	B-protein
induced	O
by	O
both	O
CD3	B-protein
and	O
CD3	B-protein
/CD28	B-protein
ligation	O
and	O
the	O
nuclear	O
expression	O
of	O
the	O
c-Jun	B-protein
and	I-protein
ATF-2	I-protein
proteins	I-protein
are	O
each	O
blocked	O
by	O
the	O
p38	B-protein
MAPK	I-protein
inhibitor	O
SB203580	O
.	O

Our	O
findings	O
demonstrate	O
that	O
p38	B-protein
MAPK	I-protein
1	O
)	O
plays	O
an	O
important	O
role	O
in	O
signal	O
integration	O
during	O
costimulation	O
of	O
primary	B-cell_type
mouse	I-cell_type
T	I-cell_type
cells	I-cell_type
,	O
2	O
)	O
may	O
be	O
involved	O
in	O
the	O
induction	O
of	O
c-Jun	B-protein
activation	O
and	O
augmentation	O
of	O
AP-1	B-protein
transcriptional	O
activity	O
,	O
and	O
3	O
)	O
regulates	O
whether	O
T	B-cell_type
cells	I-cell_type
enter	O
a	O
state	O
of	O
functional	O
unresponsiveness	O
.	O

``	NULL
n	NULL
vivo	NULL
,	NULL
RESEARCH	NULL
*	NULL
Discover	NULL
More	NULL
j	NULL
has	NULL
BULK	NULL
ANTIBODIES	NULL
as	NULL
``	NULL
a	NULL
is	NULL
meJournal	NULL
o	NULL
p38	NULL
Mitogep-Activated	NULL
P.r0tein	NULL
Kinase	NULL
'	NULL
Immunolo	NULL
gy	NULL
Mediates	NULL
Signal	NULL
Integration	NULL
of	NULL
TCR/CD28	NULL
Costimulation	NULL
in	NULL
Primary	NULL
Murine	NULL
T	NULL
Cells	NULL
This	NULL
info	NULL
tion	NULL
i	NULL
t	NULL
Jian	NULL
Zhang	NULL
,	NULL
Konstantin	NULL
V.	NULL
Salojin	NULL
,	NULL
Jian-Xin	NULL
Gao	NULL
,	NULL
Mark	NULL
J.	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
(	NULL
Elana	NULL
;	NULL
i	NULL
)	NULL
;	NULL
is	NULL
current	NULL
as	NULL
Cameron	NULL
,	NULL
Isabelle	NULL
Bergerot	NULL
and	NULL
Terry	NULL
L.	NULL
Delovitch	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:3819-3829	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/7/3819	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
54	NULL
articles	NULL
,	NULL
34	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/7/3819.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
p38	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
Mediates	NULL
Signal	NULL
Integration	NULL
of	NULL
TCR/CD28	NULL
Costimulation	NULL
in	NULL
Primary	NULL
Murine	NULL
T	NULL
Cells	NULL
!	NULL

Jian	NULL
Zhang	NULL
,	NULL
``	NULL
*	NULL
Konstantin	NULL
V.	NULL
Salojin	NULL
,	NULL
``	NULL
*	NULL
Jian-Xin	NULL
Gao	NULL
,	NULL
*	NULL
Mark	NULL
J.	NULL
Cameron	NULL
,	NULL
**	NULL
Isabelle	NULL
Bergerot	NULL
,	NULL
*	NULL
and	NULL
Terry	NULL
L.	NULL
Optimal	NULL
T	NULL
cell	NULL
activation	NULL
requires	NULL
two	NULL
signals	NULL
,	NULL
one	NULL
generated	NULL
by	NULL
TCR	NULL
and	NULL
another	NULL
by	NULL
the	NULL
CD28	NULL
costimulatory	NULL
receptor	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
regulation	NULL
of	NULL
costimulation-induced	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
activation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
Jun	NULL
NH	NULL
,	NULL
,	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
,	NULL
is	NULL
weakly	NULL
activated	NULL
upon	NULL
stimulation	NULL
with	NULL
either	NULL
anti-CD3	NULL
or	NULL
anti-CD28	NULL
in	NULL
murine	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
p38	NULL
MAPK	NULL
is	NULL
activated	NULL
strongly	NULL
and	NULL
synergistically	NULL
by	NULL
either	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
PMA/Ca**	NULL
ionophore	NULL
stimulation	NULL
,	NULL
which	NULL
mimics	NULL
TCR-CD3/CD28-mediated	NULL
signaling	NULL
.	NULL

Activation	NULL
of	NULL
p38	NULL
MAPK	NULL
correlates	NULL
closely	NULL
with	NULL
the	NULL
stimulation	NULL
of	NULL
T	NULL
cell	NULL
prolifera-tion	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PMA-induced	NULL
JNK	NULL
activation	NULL
is	NULL
inhibited	NULL
by	NULL
Ca**	NULL
ionophore	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
and	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
induced	NULL
by	NULL
both	NULL
CD3	NULL
and	NULL
CD3/CD28	NULL
ligation	NULL
and	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
proteins	NULL
are	NULL
each	NULL
blocked	NULL
by	NULL
the	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
$	NULL
B203580	NULL
.	NULL

Our	NULL
findings	NULL
demonstrate	NULL
that	NULL
p38	NULL
MAPK	NULL
1	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
,	NULL
2	NULL
)	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
activation	NULL
and	NULL
augmen-	NULL
tation	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
3	NULL
)	NULL
regulates	NULL
whether	NULL
T	NULL
cells	NULL
enter	NULL
a	NULL
state	NULL
of	NULL
functional	NULL
unresponsiveness	NULL
.	NULL

of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
3819-3829.	NULL
targets	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
is	NULL
mediated	NULL
by	NULL
several	NULL
protein	NULL
kinases	NULL
,	NULL
including	NULL
the	NULL
family	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
MAPKs	NULL
)	NULL
*	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

MAPKs	NULL
are	NULL
serine/threonine	NULL
kinases	NULL
that	NULL
include	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
(	NULL
ERKs	NULL
)	NULL
,	NULL
Jun	NULL
NH-terminal	NULL
kinases	NULL
(	NULL
JNKs	NULL
)	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

MAPKs	NULL
are	NULL
activated	NULL
by	NULL
dual	NULL
phosphorylation	NULL
in	NULL
a	NULL
Thr-Xaa-Tyr	NULL
motif	NULL
,	NULL
in	NULL
which	NULL
Xaa	NULL
corresponds	NULL
to	NULL
Glu	NULL
in	NULL
ERK	NULL
,	NULL
Pro	NULL
in	NULL
JNK	NULL
,	NULL
and	NULL
Gly	NULL
in	NULL
p38	NULL
MAPK	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

These	NULL
dual	NULL
specificity	NULL
kinases	NULL
are	NULL
relatively	NULL
specific	NULL
for	NULL
each	NULL
MAPK	NULL
subgroup	NULL
,	NULL
allowing	NULL
for	NULL
their	NULL
independent	NULL
regula-tion	NULL
.	NULL

Thus	NULL
,	NULL
MAPK/ERK	NULL
kinase-1	NULL
(	NULL
MEK-1	NULL
)	NULL
and	NULL
MEK2	NULL
selectively	NULL
phosphorylate	NULL
and	NULL
activate	NULL
ERKs	NULL
,	NULL
whereas	NULL
MAPK	NULL
kinase-3	NULL
(	NULL
MKK-3	NULL
)	NULL
and	NULL
MKK6	NULL
selectively	NULL
phosphorylate	NULL
and	NULL
activate	NULL
p38	NULL
MAPK	NULL
.	NULL

MKK4	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
ERK	NULL
subgroup	NULL
,	NULL
but	NULL
activates	NULL
both	NULL
p38	NULL
MAPK	NULL
and	NULL
JNK	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

T	NULL
he	NULL
transmission	NULL
of	NULL
extracellular	NULL
signals	NULL
to	NULL
intracellular	NULL
*Autoimmunity/Diabetes	NULL
Group	NULL
,	NULL
John	NULL
P.	NULL
Robarts	NULL
Research	NULL
Institute	NULL
,	NULL
London	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
;	NULL
and	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
and	NULL
*Medicine	NULL
,	NULL
University	NULL
of	NULL
Western	NULL
Ontario	NULL
,	NULL
London	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
10	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
21	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Vern	NULL
Bruder	NULL
Grant	NULL
from	NULL
the	NULL
Canadian	NULL
Diabetes	NULL
Association	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Juvenile	NULL
Diabetes	NULL
Foundation	NULL
International	NULL
(	NULL
to	NULL
TLD	NULL
.	NULL
)	NULL

.	NULL

J.Z	NULL
.	NULL

and	NULL
K.V.S	NULL
.	NULL

were	NULL
recipients	NULL
of	NULL
Juvenile	NULL
Diabetes	NULL
Foundation	NULL
International	NULL
postdoctoral	NULL
fellowships	NULL
.	NULL

2	NULL
1.Z	NULL
.	NULL

and	NULL
K.V.S	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

3	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Terry	NULL
L.	NULL
Delovitch	NULL
,	NULL
Autoim-munity/Diabetes	NULL
Group	NULL
,	NULL
John	NULL
P.	NULL
Robarts	NULL
Research	NULL
Institute	NULL
,	NULL
1400	NULL
Western	NULL
Road	NULL
,	NULL
London	NULL
,	NULL
Ontario	NULL
N6G	NULL
2V4	NULL
,	NULL
Canada	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
del	NULL
@	NULL
rri.on.ca	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
ATF-2	NULL
,	NULL
activating	NULL
transcription	NULL
factor-2	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
hsp	NULL
,	NULL
heat-shock	NULL
protein	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
NH	NULL
;	NULL
-terminal	NULL
kinase	NULL
;	NULL
MAPKAP	NULL
,	NULL
MAPK-activating	NULL
protein	NULL
;	NULL
MBP	NULL
,	NULL
myelin	NULL
basic	NULL
protein	NULL
;	NULL
MEK	NULL
,	NULL
MAP	NULL
kinase/ERK	NULL
kinase	NULL
;	NULL
MKK	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
ERKs	NULL
are	NULL
activated	NULL
by	NULL
agonists	NULL
for	NULL
tyrosine-encoded	NULL
receptors	NULL
and	NULL
G	NULL
protein-coupled	NULL
receptors	NULL
that	NULL
induce	NULL
mitogenesis	NULL
or	NULL
cellular	NULL
differentiation	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

ERKs	NULL
mediate	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
agonists	NULL
by	NULL
phosphorylating	NULL
and	NULL
regulating	NULL
the	NULL
activity	NULL
of	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
cytoplasmic	NULL
enzymes	NULL
and	NULL
nuclear	NULL
factors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

JNKs	NULL
phosphorylate	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
activation	NULL
domain	NULL
of	NULL
c-Jun	NULL
and	NULL
activating	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
,	NULL
increasing	NULL
their	NULL
transcriptional	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

JNKs	NULL
are	NULL
activated	NULL
preferentially	NULL
by	NULL
cellular	NULL
stress	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
but	NULL
also	NULL
by	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
agonists	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
cytoplasmic	NULL
onco-genes	NULL
(	NULL
4	NULL
,	NULL
10-16	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
p38	NULL
MAPK	NULL
is	NULL
activated	NULL
by	NULL
cellular	NULL
stresses	NULL
,	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
LPS	NULL
(	NULL
14	NULL
,	NULL
17-19	NULL
)	NULL
,	NULL
and	NULL
G	NULL
protein-coupled	NULL
receptors	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
activated	NULL
p38	NULL
MAPK	NULL
in	NULL
turn	NULL
mediates	NULL
cytokine	NULL
production	NULL
,	NULL
stress	NULL
responses	NULL
,	NULL
and	NULL
apoptosis	NULL
(	NULL
21-26	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAPK	NULL
substrates	NULL
include	NULL
MAPK-activating	NULL
protein	NULL
kinase-2	NULL
(	NULL
MAPKAP	NULL
kinase-2	NULL
)	NULL
,	NULL
ATFE-2	NULL
(	NULL
18	NULL
,	NULL
19	NULL
,	NULL
27	NULL
,	NULL
28	NULL
)	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
,	NULL
ATF-1	NULL
(	NULL
29	NULL
)	NULL
,	NULL
Elk-1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
C/EBP-homologous	NULL
protein	NULL
(	NULL
CHOP	NULL
)	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
myocyte-enhancer	NULL
factor	NULL
2C	NULL
(	NULL
MEFZC	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

TCR	NULL
engagement	NULL
activates	NULL
the	NULL
ERK	NULL
cascade	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
32-34	NULL
)	NULL
.	NULL

Analyses	NULL
of	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
various	NULL
activated	NULL
mouse	NULL
T	NULL
cell	NULL
clones	NULL
have	NULL
suggested	NULL
that	NULL
JNK	NULL
activation	NULL
stimulated	NULL
by	NULL
TCR	NULL
engagement	NULL
requires	NULL
CD28	NULL
coligation	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

p38	NULL
MAPK	NULL
may	NULL
be	NULL
fully	NULL
activated	NULL
in	NULL
mouse	NULL
T	NULL
cell	NULL
clones	NULL
by	NULL
signaling	NULL
via	NULL
either	NULL
CD3	NULL
or	NULL
CD28	NULL
,	NULL
but	NULL
CD3/CD28	NULL
costimulation	NULL
does	NULL
not	NULL
further	NULL
enhance	NULL
the	NULL
amount	NULL
of	NULL
p38	NULL
MAPK	NULL
activation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimulation	NULL
of	NULL
CD28	NULL
fails	NULL
to	NULL
activate	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
synergizes	NULL
with	NULL
CD3	NULL
stimulation	NULL
to	NULL
fully	NULL
activate	NULL
p38	NULL
MAPK	NULL
in	NULL
preactivated	NULL
proliferating	NULL
T	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

These	NULL
results	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
p38	NULL
MAPK	NULL
may	NULL
mediate	NULL
CD28	NULL
costimulation	NULL
in	NULL
primary	NULL
naive	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
latter	NULL
possibility	NULL
is	NULL
supported	NULL
by	NULL
reports	NULL
that	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
MKK-4-deficient	NULL
mice	NULL
,	NULL
CD28-mediated	NULL
IL-2	NULL
production	NULL
and	NULL
proliferation	NULL
are	NULL
impaired	NULL
and	NULL
CD28	NULL
costimulation	NULL
and	NULL
PMA/Ca**	NULL
ionophore-induced	NULL
signaling	NULL
can	NULL
stimulate	NULL
proliferation	NULL
and	NULL
IL-2	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3820	NULL
production	NULL
independently	NULL
of	NULL
JNK	NULL
activation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
SB203580	NULL
blocks	NULL
CD28-dependent	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
p38	NULL
MAPK	NULL
is	NULL
activated	NULL
upon	NULL
either	NULL
TCR	NULL
or	NULL
CD28	NULL
stimulation	NULL
or	NULL
after	NULL
TCR/CD28	NULL
coligation	NULL
in	NULL
primary	NULL
,	NULL
unstimu-lated	NULL
,	NULL
naive	NULL
mouse	NULL
T	NULL
cells	NULL
merits	NULL
further	NULL
investigation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
differential	NULL
regulation	NULL
of	NULL
MAPK	NULL
activation	NULL
occurs	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
TCR/CD28	NULL
or	NULL
PMA/Ca®*	NULL
ionophore	NULL
costimulation	NULL
.	NULL

We	NULL
show	NULL
that	NULL
p38	NULL
MAPK	NULL
activation	NULL
mediates	NULL
both	NULL
TCR-	NULL
and	NULL
CD28-induced	NULL
signaling	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Ligation	NULL
of	NULL
TCR	NULL
or	NULL
CD28	NULL
results	NULL
in	NULL
only	NULL
modest	NULL
p38	NULL
MAPK	NULL
activation	NULL
,	NULL
whereas	NULL
TCR	NULL
and	NULL
CD28	NULL
synergize	NULL
upon	NULL
coligation	NULL
to	NULL
elicit	NULL
enhanced	NULL
p38	NULL
MAPK	NULL
activation	NULL
.	NULL

PMA/Ca®*	NULL
ionophore	NULL
costimulation	NULL
,	NULL
which	NULL
mimics	NULL
TCR/	NULL
CD28-mediated	NULL
signaling	NULL
,	NULL
fully	NULL
activates	NULL
p38	NULL
MAPK	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
p38	NULL
MAPK	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
TCR-	NULL
and	NULL
CD28-signaling	NULL
pathways	NULL
,	NULL
and	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
naive	NULL
mouse	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
C57BL/6	NULL
(	NULL
B6	NULL
)	NULL
and	NULL
BALB/c	NULL
mice	NULL
were	NULL
purchased	NULL
from	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
(	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
,	NULL
maintained	NULL
in	NULL
the	NULL
Animal	NULL
Care	NULL
Facility	NULL
of	NULL
the	NULL
Faculty	NULL
of	NULL
Medicine	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Western	NULL
Ontario	NULL
(	NULL
London	NULL
,	NULL
ON	NULL
,	NULL
Canada	NULL
)	NULL
,	NULL
and	NULL
used	NULL
at	NULL
6-10	NULL
wk	NULL
of	NULL
age	NULL
.	NULL

Abs	NULL
,	NULL
proteins	NULL
,	NULL
and	NULL
reagents	NULL
The	NULL
following	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
:	NULL
rabbit	NULL
polyclonal	NULL
Abs	NULL
against	NULL
mouse	NULL
ERK-1	NULL
,	NULL
JINK-1/2	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
;	NULL
mouse	NULL
mAbs	NULL
against	NULL
c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
ATF-2	NULL
;	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
,	NULL
GST-ATF-2	NULL
(	NULL
1-505	NULL
)	NULL
,	NULL
and	NULL
glutathione-agarose	NULL
.	NULL

MBP	NULL
,	NULL
IL-2	NULL
,	NULL
cycloheximide	NULL
,	NULL
and	NULL
PMA	NULL
were	NULL
each	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Anti-MAPKAP	NULL
kinase-2	NULL
antiserum	NULL
and	NULL
recombinant	NULL
murine	NULL
heat-shock	NULL
protein	NULL
25	NULL
(	NULL
hsp25	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
StressGen	NULL
Biotechnology	NULL
(	NULL
Victoria	NULL
,	NULL
Canada	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
145-2C11	NULL
anti-CD3	NULL
and	NULL
37.51	NULL
anti-CD28	NULL
mAbs	NULL
were	NULL
purified	NULL
by	NULL
protein	NULL
G	NULL
affinity	NULL
chromatography	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
of	NULL
the	NULL
supernatants	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
hybridomas	NULL
kindly	NULL
supplied	NULL
by	NULL
Dr.	NULL
J.	NULL
Bluestone	NULL
(	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
Dr.	NULL
J.	NULL
Allison	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
PV-1	NULL
anti-CD28	NULL
mAb	NULL
was	NULL
kindly	NULL
supplied	NULL
by	NULL
Dr.	NULL
C.	NULL
June	NULL
(	NULL
Naval	NULL
Medical	NULL
Research	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
203580	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
Young	NULL
(	NULL
SmithKline	NULL
Beecham	NULL
Pharmaceu-ticals	NULL
,	NULL
King	NULL
of	NULL
Prussia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
was	NULL
supplied	NULL
by	NULL
Sandoz	NULL
Canada	NULL
(	NULL
Dorval	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
anti-human	NULL
CD3	NULL
(	NULL
OKT3	NULL
)	NULL
and	NULL
CD28	NULL
mAbs	NULL
were	NULL
obtained	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
A23187	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

IL-2	NULL
and	NULL
cycloheximide	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Cell	NULL
isolation	NULL
and	NULL
stimulation	NULL
B6	NULL
and	NULL
BALB/c	NULL
thymocytes	NULL
or	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
(	NULL
purity	NULL
>	NULL
=98	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
of	NULL
CD3	NULL
cell	NULL
surface	NULL
expression	NULL
)	NULL
on	NULL
T	NULL
cell	NULL
enrichment	NULL
columns	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Murine	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
5	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
0.1	NULL
mg/ml	NULL
strep-tomycin	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
0.05	NULL
uM	NULL
2-ME	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
(	NULL
all	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Burlington	NULL
,	NULL
ON	NULL
,	NULL
Canada	NULL
)	NULL
before	NULL
stimulation	NULL
to	NULL
decrease	NULL
high	NULL
basal	NULL
levels	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
either	NULL
the	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
mAbs	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
plus	NULL
the	NULL
Ca**	NULL
ionophore	NULL
A23187	NULL
.	NULL

Jurkat	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
also	NULL
grown	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

After	NULL
culture	NULL
,	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10'/ml	NULL
)	NULL
were	NULL
resuspended	NULL
at	NULL
37°C	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
stimulated	NULL
as	NULL
above	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
$	NULL
B203580	NULL
or	NULL
CsA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
15	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

To	NULL
obtain	NULL
proliferating	NULL
T	NULL
cells	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
(	NULL
10°/ml	NULL
)	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
in	NULL
six-well	NULL
plates	NULL
precoated	NULL
with	NULL
anti-CD3	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
20	NULL
After	NULL
48	NULL
h	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
plates	NULL
and	NULL
expanded	NULL
in	NULL
IL-2	NULL
.	NULL

Proliferating	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
4	NULL
of	NULL
culture	NULL
,	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
mAbs	NULL
.	NULL

COSTIMULATORY	NULL
ACTIVATION	NULL
OF	NULL
p38	NULL
MAPK	NULL
IN	NULL
PRIMARY	NULL
T	NULL
CELLS	NULL
In	NULL
vitro	NULL
kinase	NULL
assays	NULL
After	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
2	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
10	NULL
pg/ml	NULL
apoptinin	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
their	NULL
protein	NULL
content	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
using	NULL
BSA	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Lysates	NULL
were	NULL
divided	NULL
into	NULL
three	NULL
replicate	NULL
samples	NULL
;	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
either	NULL
anti-ERK-1	NULL
,	NULL
anti-JNK-1	NULL
,	NULL
or	NULL
anti-p38	NULL
MAPK	NULL
Abs	NULL
;	NULL
and	NULL
further	NULL
reacted	NULL
with	NULL
protein	NULL
G	NULL
agarose	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
or	NULL
protein	NULL
A-Sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Baie	NULL
d'Urfe	NULL
,	NULL
PQ	NULL
,	NULL
Canada	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
twice	NULL
with	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
mM	NULL
MnCl	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
25	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
and	NULL
100	NULL
nM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
)	NULL
.	NULL

Kinase	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
MBP	NULL
,	NULL
GST-c-Jun	NULL
,	NULL
and	NULL
GST-ATF-2	NULL
fusion	NULL
proteins	NULL
as	NULL
substrates	NULL
for	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
,	NULL
respectively	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
resuspended	NULL
in	NULL
18	NULL
pl	NULL
kinase	NULL
buffer	NULL
containing	NULL
5	NULL
pg	NULL
MBP	NULL
,	NULL
1	NULL
ug	NULL
GST-c-Jun	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
GST-ATF-2	NULL
fusion	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
uM	NULL
cold	NULL
ATP	NULL
and	NULL
20	NULL
uCi	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
(	NULL
Amersham	NULL
Life	NULL
Science	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

Solid-phase	NULL
JNK	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cell	NULL
equivalents	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
reacted	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
a	NULL
GST-c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
fusion	NULL
protein	NULL
bound	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
to	NULL
immobilize	NULL
JNK	NULL
.	NULL

The	NULL
washed	NULL
beads	NULL
were	NULL
then	NULL
analyzed	NULL
for	NULL
their	NULL
associated	NULL
kinase	NULL
activity	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
kinase	NULL
buffer	NULL
containing	NULL
20	NULL
wCi	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
samples	NULL
were	NULL
boiled	NULL
,	NULL
and	NULL
kinase	NULL
reaction	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
MAPKAP	NULL
kinase-2	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
,	NULL
using	NULL
murine	NULL
recombinant	NULL
hsp25	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
precipitated	NULL
proteins	NULL
was	NULL
confirmed	NULL
by	NULL
probing	NULL
the	NULL
blots	NULL
with	NULL
specific	NULL
Abs	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
substrates	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
Molecular	NULL
Imager	NULL
System	NULL
and	NULL
Molecular	NULL
Analyst	NULL
imaging	NULL
software	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
assay	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10°/ml	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
round-bottom	NULL
96-well	NULL
plates	NULL
(	NULL
Nunc	NULL
)	NULL
precoated	NULL
with	NULL
the	NULL
145-2C11	NULL
anti-CD3e	NULL
mAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

(	NULL
1	NULL
wCi/well	NULL
;	NULL
Amersham	NULL
)	NULL
was	NULL
added	NULL
24	NULL
h	NULL
before	NULL
the	NULL
end	NULL
of	NULL
culture	NULL
,	NULL
and	NULL
cultures	NULL
were	NULL
harvested	NULL
using	NULL
a	NULL
Tomtec	NULL
Harvester	NULL
96	NULL
cell	NULL
harvester	NULL
(	NULL
Fisher	NULL
Scientific	NULL
,	NULL
Ottawa	NULL
,	NULL
ON	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
midine	NULL
incorporation	NULL
,	NULL
which	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Wallac	NULL
1450	NULL
Micro-beta	NULL
Plus	NULL
beta	NULL
counter	NULL
(	NULL
Fisher	NULL
Scientific	NULL
)	NULL
.	NULL

Cytokine	NULL
assays	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10°/ml	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
$	NULL
B203580	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
round-bottom	NULL
96-well	NULL
plates	NULL
coated	NULL
with	NULL
anti-CD3	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

Supernatants	NULL
collected	NULL
after	NULL
48	NULL
h	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
cytokine	NULL
concentrations	NULL
by	NULL
ELISA	NULL
using	NULL
a	NULL
double	NULL
ligand	NULL
method	NULL
.	NULL

IL-2	NULL
concentrations	NULL
were	NULL
interpolated	NULL
from	NULL
a	NULL
standard	NULL
curve	NULL
using	NULL
murine	NULL
rIL-2	NULL
captured	NULL
by	NULL
the	NULL
JES6-1A12	NULL
mAb	NULL
and	NULL
detected	NULL
by	NULL
the	NULL
biotinylated	NULL
JES6-5H4	NULL
mAb	NULL
.	NULL

IL-4	NULL
concentrations	NULL
were	NULL
measured	NULL
using	NULL
recombinant	NULL
murine	NULL
IL-4	NULL
,	NULL
the	NULL
BVD4-1D11	NULL
mAb	NULL
,	NULL
and	NULL
biotinylated	NULL
BVD6-24G2	NULL
mAb	NULL
,	NULL
while	NULL
IFN-y	NULL
concentrations	NULL
were	NULL
detected	NULL
using	NULL
recombinant	NULL
murine	NULL
IFN-y	NULL
,	NULL
R4-6A2	NULL
mAb	NULL
,	NULL
and	NULL
biotinylated	NULL
XMG1.2	NULL
mAb	NULL
(	NULL
all	NULL
obtained	NULL
from	NULL
PharMingen	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
flat-bottom	NULL
96-well	NULL
microtiter	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
50	NULL
pl/well	NULL
of	NULL
capture	NULL
mAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
in	NULL
0.1	NULL
M	NULL
NaHCO	NULL
;	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Nonspecific	NULL
binding	NULL
sites	NULL
were	NULL
blocked	NULL
with	NULL
3	NULL
%	NULL
BSA	NULL
for	NULL
2	NULL
h	NULL
at	NULL
23°C	NULL
.	NULL

Standards	NULL
or	NULL
samples	NULL
(	NULL
50	NULL
pl	NULL
)	NULL
were	NULL
added	NULL
,	NULL
left	NULL
overnight	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
50	NULL
ul/well	NULL
of	NULL
biotinylated	NULL
detecting	NULL
mAb	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
45	NULL
min	NULL
at	NULL
23°C	NULL
.	NULL

Streptavidin-peroxidase	NULL
conjugates	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
in	NULL
diethanolamine	NULL
buffer	NULL
were	NULL
successively	NULL
added	NULL
to	NULL
develop	NULL
the	NULL
reaction	NULL
at	NULL
23°C	NULL
.	NULL

Plates	NULL
were	NULL
read	NULL
at	NULL
405	NULL
nm	NULL
in	NULL
an	NULL
automated	NULL
microplate	NULL
reader	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Cytokine	NULL
standard	NULL
curves	NULL
were	NULL
linear	NULL
in	NULL
the	NULL
range	NULL
of	NULL
20-20,000	NULL
pg/ml	NULL
.	NULL

Cell	NULL
viability	NULL
assay	NULL
Splenic	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
an	NULL
anti-CD3	NULL
mAb	NULL
as	NULL
above	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
incubation	NULL
for	NULL
48	NULL
h	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3821	NULL
A	NULL
Thymocytes	NULL
B	NULL
Splenic	NULL
T	NULL
Cells	NULL
anti-CD3	NULL
:	NULL
>	NULL
=	NULL
$	NULL
00	NULL
+	NULL
(	NULL
%	NULL
)	NULL
>	NULL
anti-CD3	NULL
:	NULL
-	NULL
+0	NULL
-	NULL
40	NULL
-	NULL
.	NULL

anti-CD28	NULL
:	NULL
-	NULL
~~	NULL
#	NULL
0	NULL
#	NULL
of	NULL
anti-CD28	NULL
:	NULL
>	NULL
-	NULL
-	NULL
4	NULL
&	NULL
0	NULL
4	NULL
-	NULL
PMA	NULL
:	NULL
-	NULL
0	NULL
>	NULL
}	NULL
>	NULL
+	NULL
PMA	NULL
:	NULL
>	NULL
>	NULL
>	NULL
>	NULL
4	NULL
-	NULL
0	NULL
%	NULL
IP	NULL
:	NULL
yok	NULL
k	NULL
0	NULL
.	NULL

&	NULL
0	NULL
%	NULL
inner	NULL
.	NULL

1	NULL
--	NULL
me	NULL
-	NULL
meee	NULL
)	NULL
<	NULL
<	NULL
ver	NULL
*_*	NULL
IP	NULL
:	NULL
MBP	NULL
18	NULL
[	NULL
Enr	NULL
ony	NULL
aap	NULL
ae	NULL
)	NULL
«	NULL
@	NULL
-	NULL
@	NULL
coun	NULL
an	NULL
-	NULL
%	NULL
IP	NULL
:	NULL
``	NULL
moots	NULL
[	NULL
L	NULL
wer	NULL
O-	NULL
ug	NULL
coun	NULL
IP	NULL
:	NULL
:	NULL
p.	NULL
15	NULL
)	NULL
mee	NULL
maen	NULL
]	NULL
ap	NULL
p38	NULL
mips	NULL
it	NULL
[	NULL
<	NULL
a	NULL
ae	NULL
=	NULL
-	NULL
--	NULL
]	NULL
<	NULL
ns	NULL
C	NULL
Thymocytes	NULL
anti-CD3	NULL
:	NULL
-	NULL
0	NULL
£00	NULL
.	NULL

4	NULL
anti-CD28	NULL
:	NULL
;	NULL
=-	NULL
-	NULL
+	NULL
+0	NULL
PMA	NULL
:	NULL
-	NULL
-	NULL
%	NULL
-	NULL
0	NULL
+	NULL
IP	NULL
:	NULL
antanica	NULL
[	NULL
___	NULL
___	NULL
-	NULL
_	NULL
_-	NULL
@	NULL
]	NULL
gon	NULL
anti-CD3	NULL
:	NULL
-	NULL
4+	NULL
-	NULL
+0	NULL
-~	NULL
>	NULL
-anti-CD28	NULL
:	NULL
00	NULL
.	NULL

+	NULL
+	NULL
E	NULL
PMA	NULL
:	NULL
=	NULL
>	NULL
>	NULL
>	NULL
>	NULL
4+	NULL
>	NULL
%	NULL
AZ3187	NULL
:	NULL
;	NULL
}	NULL
.	NULL

.	NULL

.	NULL

.	NULL

£	NULL
&	NULL
FIGURE	NULL
1.	NULL
.	NULL

MAPK	NULL
activation	NULL
is	NULL
differentially	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
CD3	NULL
plus	NULL
CD28	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
Ca**	NULL
ionophore	NULL
.	NULL

A	NULL
,	NULL
Thymocytes	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
/ml	NULL
)	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
anti-CD3	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-CD28	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
precleared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-ERK-1	NULL
,	NULL
anti-JNK-1	NULL
,	NULL
or	NULL
anti-p38	NULL
MAPK	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
performed	NULL
using	NULL
MBP	NULL
,	NULL
GST-c-Jun	NULL
,	NULL
and	NULL
GST-ATF-2	NULL
as	NULL
substrates	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
by	NULL
immunoblotting	NULL
(	NULL
IB	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activity	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
A.	NULL
Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
by	NULL
IB	NULL
.	NULL

C	NULL
,	NULL
Thymocytes	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
,	NULL
and	NULL
JNK-2	NULL
activity	NULL
was	NULL
assayed	NULL
as	NULL
in	NULL
A.	NULL
Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
JNK-2	NULL
,	NULL
as	NULL
above	NULL
.	NULL

Alternatively	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
reacted	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
10	NULL
ug	NULL
GST-c-Jun	NULL
precoupled	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
reaction	NULL
(	NULL
C	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Effect	NULL
of	NULL
$	NULL
B203580	NULL
on	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
Thymocytes	NULL
(	NULL
4	NULL
X	NULL
10'/ml	NULL
)	NULL
were	NULL
pretreated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
10	NULL
uM	NULL
$	NULL
B203580	NULL
,	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
for	NULL
5	NULL
or	NULL
15	NULL
min	NULL
with	NULL
anti-CD3	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
anti-CD28	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
thymocytes	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
collected	NULL
,	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
lysed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
hypotonic	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
0.4	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
2.5	NULL
mM	NULL
PMSF	NULL
,	NULL
40	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
40	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
NaF	NULL
)	NULL
.	NULL

Nuclear	NULL
extraction	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-c-Fos	NULL
,	NULL
anti-c-Jun	NULL
,	NULL
and	NULL
anti-ATF-2	NULL
mAbs	NULL
,	NULL
and	NULL
the	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
chemoluminescence	NULL
.	NULL

Results	NULL
Coligation	NULL
of	NULL
TCR	NULL
and	NULL
CD28	NULL
synergistically	NULL
activates	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
neither	NULL
JNK	NULL
nor	NULL
ERK	NULL
in	NULL
murine	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
JNK	NULL
activation	NULL
requires	NULL
costimulation	NULL
by	NULL
either	NULL
CD28	NULL
or	NULL
Ca**	NULL
ionophore	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
T	NULL
cell	NULL
costimulation	NULL
(	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
activation	NULL
of	NULL
JNK	NULL
and	NULL
p38	NULL
MAPK	NULL
occurs	NULL
in	NULL
primary	NULL
naive	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
not	NULL
further	NULL
stimulated	NULL
in	NULL
vitro	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
CD28	NULL
regulates	NULL
MAPK	NULL
activation	NULL
following	NULL
CD3	NULL
ligation	NULL
,	NULL
murine	NULL
thymocytes	NULL
or	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
or	NULL
both	NULL
mAbs	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
;	NULL
ERK-1	NULL
,	NULL
JINK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
Abs	NULL
;	NULL
and	NULL
immunoprecipitates	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
activities	NULL
of	NULL
associated	NULL
MAPKs	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
phosphorylate	NULL
the	NULL
MBP	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
substrates	NULL
,	NULL
respectively	NULL
.	NULL

Anti-CD3	NULL
stimulation	NULL
activated	NULL
ERK-1	NULL
in	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
level	NULL
of	NULL
activation	NULL
of	NULL
ERK-1	NULL
was	NULL
not	NULL
increased	NULL
after	NULL
CD3/CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
upper	NULL
panels	NULL
)	NULL
,	NULL
as	NULL
reported	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

More	NULL
significantly	NULL
,	NULL
stimulation	NULL
by	NULL
anti-CD3	NULL
or	NULL
anti-CD28	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
did	NULL
not	NULL
activate	NULL
JNK	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
JNK-1	NULL
)	NULL
in	NULL
murine	NULL
thymocytes	NULL
or	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
middle	NULL
panels	NULL
)	NULL
.	NULL

Anti-CD3	NULL
or	NULL
anti-CD28	NULL
stimulation	NULL
induced	NULL
modest	NULL
p38	NULL
MAPK	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
elevated	NULL
about	NULL
fivefold	NULL
after	NULL
CD3/CD28	NULL
coligation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

PMA	NULL
activated	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
Ca**	NULL
ionophore	NULL
A23187	NULL
did	NULL
not	NULL
activate	NULL
ERK-1	NULL
or	NULL
JNK-1	NULL
,	NULL
but	NULL
rather	NULL
stimulated	NULL
p38	NULL
MAPK	NULL
activity	NULL
and	NULL
enhanced	NULL
the	NULL
level	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
induced	NULL
by	NULL
PMA	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

JINK-2	NULL
may	NULL
bind	NULL
and	NULL
phosphorylate	NULL
c-Jun	NULL
more	NULL
efficiently	NULL
than	NULL
JNK-1	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

To	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3822	NULL
COSTIMULATORY	NULL
ACTIVATION	NULL
OF	NULL
p38	NULL
MAPK	NULL
IN	NULL
PRIMARY	NULL
T	NULL
CELLS	NULL
FIGURE	NULL
2.	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
ERK-1	NULL
A	NULL
anti-CD3	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
B	NULL
or	NULL
JNK-1	NULL
,	NULL
is	NULL
synergistically	NULL
activated	NULL
by	NULL
CD3/	NULL
*	NULL
.	NULL

CD28	NULL
coligation	NULL
.	NULL

A	NULL
,	NULL
Thymocytes	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
/	NULL
2	NULL
ant-obze	NULL
(	NULL
tug/m	NULL
!	NULL
)	NULL

:	NULL
\_	NULL
snf-eDyCD28	NULL
(	NULL
min	NULL
}	NULL
:	NULL
_	NULL
ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
control	NULL
normal	NULL
ham-	NULL
1p	NULL
:	NULL
2	NULL
f	NULL
MC	NULL
_J	NULL
1C	NULL
2	NULL
1p	NULL
:	NULL
o_	NULL
is	NULL
36	NULL
so	NULL
120	NULL
ster	NULL
IgG	NULL
(	NULL
Nig	NULL
,	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
with	NULL
anti-CD3	NULL
anti-Eng.1	NULL
|___	NULL
same	NULL
cmm	NULL
mme	NULL
mme	NULL
sass	NULL
«	NULL
|	NULL
«	NULL
alk	NULL
MBP	NULL
antienk1	NULL
|___	NULL
@	NULL
@	NULL
+	NULL
#	NULL
.	NULL

-	NULL
mep	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

plus	NULL
incremental	NULL
concentrations	NULL
IB	NULL
|	NULL
me	NULL
mo	NULL
»	NULL
mom	NULL
mom	NULL
sm	NULL
com	NULL
**	NULL
|	NULL
«	NULL
li-	NULL
ERK-1	NULL
IB|	NULL
--	NULL
some	NULL
<	NULL
ue	NULL
<	NULL
<	NULL
mel	NULL
ERK-1	NULL
(	NULL
0-20	NULL
pg/ml	NULL
!	NULL
)	NULL

of	NULL
anti-CD28	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
IP	NULL
:	NULL
I	NULL
%	NULL
iP	NULL
:	NULL
with	NULL
antERK-L1	NULL
,	NULL
anl	NULL
INK.1	NULL
,	NULL
or	NULL
anipas	NULL
-	NULL
[	NULL
L	NULL
n	NULL
]	NULL
oen	NULL
.	NULL

Pinang	NULL
[	NULL
_-	NULL
_-_	NULL
__	NULL
]	NULL
MAPK	NULL
,	NULL
and	NULL
kinase	NULL
activities	NULL
were	NULL
assayed	NULL
as	NULL
ip	NULL
|x	NULL
we	NULL
we	NULL
%	NULL
n	NULL
«	NULL
lll	NULL
JNK-1	NULL
18	NULL
ﬂ-UNK-i	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p378	NULL
£3	NULL
:	NULL
le	NULL
”	NULL
m	NULL
-	NULL
.	NULL

--	NULL
-	NULL
'	NULL
.	NULL

‘	NULL
.	NULL

ATF-2	NULL
lath	NULL
”	NULL
Eﬂ-ATF-z	NULL
MD	NULL
were	NULL
smae	NULL
?	NULL

wit	NULL
wop	NULL
CD5	NULL
010	NULL
wat	NULL
is	NULL
[	NULL
mw	NULL
waw	NULL
cme	NULL
mes	NULL
cos	NULL
mme	NULL
m	NULL
]	NULL
-	NULL
<	NULL
G-p38	NULL
is	NULL
(	NULL
ze	NULL
sm	NULL
mm	NULL
an	NULL
pss	NULL
ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/	NULL
ml	NULL
)	NULL
plus	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
0	NULL
,	NULL
15	NULL
,	NULL
30	NULL
,	NULL
60	NULL
,	NULL
and	NULL
120	NULL
min	NULL
.	NULL

ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
C	NULL
MAPK	NULL
activities	NULL
associated	NULL
with	NULL
immunoprecipitates	NULL
were	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
,	NULL
as	NULL
above	NULL
.	NULL

C	NULL
,	NULL
Stimulation	NULL
of	NULL
thymocytes	NULL
(	NULL
2	NULL
X	NULL
10'/ml	NULL
)	NULL
with	NULL
Nig	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
with	NULL
anti-CD28	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
plus	NULL
incremental	NULL
concentrations	NULL
(	NULL
0-20	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
of	NULL
anti-CD3	NULL
,	NULL
and	NULL
assay	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activities	NULL
were	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
,	NULL
as	NULL
above	NULL
.	NULL

D	NULL
,	NULL
Thymocytes	NULL
(	NULL
2	NULL
X	NULL
10'/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
Nig	NULL
(	NULL
10	NULL
pug/m	NULL
!	NULL
)	NULL

,	NULL
PV-1	NULL
anti-CD28	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

plus	NULL
incremental	NULL
concentrations	NULL
(	NULL
0-20	NULL
pg/ml	NULL
!	NULL
)	NULL

of	NULL
PV-1	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-JINK-1	NULL
polyclonal	NULL
Abs	NULL
,	NULL
and	NULL
JNK-1	NULL
activities	NULL
were	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

The	NULL
loading	NULL
of	NULL
equal	NULL
amounts	NULL
of	NULL
JNK-1	NULL
proteins	NULL
was	NULL
confirmed	NULL
by	NULL
anti-JNK-1	NULL
immunoblotting	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
two	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

exclude	NULL
the	NULL
possibility	NULL
that	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
JINK-2	NULL
may	NULL
be	NULL
solely	NULL
responsible	NULL
for	NULL
c-Jun	NULL
phosphorylation	NULL
,	NULL
thymocytes	NULL
were	NULL
lysed	NULL
following	NULL
stimulation	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
anti-CD3	NULL
plus	NULL
CD28	NULL
,	NULL
or	NULL
PMA	NULL
.	NULL

JNK-2	NULL
activity	NULL
associated	NULL
with	NULL
anti-JNK-2	NULL
imnmunoprecipitates	NULL
was	NULL
examined	NULL
by	NULL
c-Jun	NULL
phosphorylation	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
.	NULL

As	NULL
observed	NULL
for	NULL
JINK-1	NULL
,	NULL
little	NULL
or	NULL
no	NULL
JNK-2	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
response	NULL
to	NULL
ligation	NULL
of	NULL
either	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
both	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

JINK-2	NULL
was	NULL
activated	NULL
,	NULL
however	NULL
,	NULL
by	NULL
PMA	NULL
stimulation	NULL
.	NULL

The	NULL
failure	NULL
to	NULL
activate	NULL
JNK-1	NULL
and	NULL
JNK-2	NULL
by	NULL
coligation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
BALB/c	NULL
splenic	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
observations	NULL
are	NULL
not	NULL
mouse	NULL
strain	NULL
dependent	NULL
.	NULL

Since	NULL
several	NULL
splice	NULL
variants	NULL
of	NULL
JINK-1	NULL
and	NULL
JNK-2	NULL
have	NULL
been	NULL
found	NULL
recently	NULL
(	NULL
43	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
anti-JNK	NULL
Abs	NULL
used	NULL
may	NULL
not	NULL
precipitate	NULL
all	NULL
variant	NULL
forms	NULL
of	NULL
JNK	NULL
.	NULL

To	NULL
eliminate	NULL
this	NULL
possibility	NULL
,	NULL
GST-c-Jun	NULL
precoupled	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
was	NULL
used	NULL
in	NULL
a	NULL
solid-phase	NULL
JNK	NULL
assay	NULL
to	NULL
precipitate	NULL
all	NULL
JNK	NULL
variants	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
of	NULL
JNK-1	NULL
,	NULL
c-Jun	NULL
phosphorylation	NULL
was	NULL
not	NULL
increased	NULL
upon	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
,	NULL
but	NULL
was	NULL
induced	NULL
significantly	NULL
upon	NULL
PMA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
activation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
induced	NULL
by	NULL
stimulation	NULL
of	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
CD3	NULL
plus	NULL
CD28	NULL
,	NULL
thymocytes	NULL
were	NULL
pretreated	NULL
with	NULL
a	NULL
constant	NULL
amount	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
of	NULL
anti-CD3	NULL
together	NULL
with	NULL
variable	NULL
amounts	NULL
of	NULL
anti-CD28	NULL
.	NULL

With	NULL
increasing	NULL
concentrations	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
0.1-20	NULL
pg/ml	NULL
)	NULL
,	NULL
no	NULL
further	NULL
augmentation	NULL
of	NULL
ERK-1	NULL
activation	NULL
was	NULL
observed	NULL
compared	NULL
IP	NULL
:	NULL
anti-JNK-1	NULL
anti-CD28	NULL
(	NULL
5	NULL
ug/m	NULL
!	NULL
)	NULL

+	NULL
g	NULL
anti-CD3	NULL
(	NULL
ug/m	NULL
!	NULL
)	NULL

:	NULL
0	NULL
0.1	NULL
1	NULL
5	NULL
10	NULL
20	NULL
IP	NULL
:	NULL
anti-ERK-1	NULL
«	NULL
»	NULL
CB	NULL
amie	NULL
|	NULL
--	NULL
mor	NULL
IB	NULL
|a	NULL
as	NULL
MMH	NULL
(	NULL
ou	NULL
duet	NULL
test	NULL
$	NULL
t	NULL
Cu	NULL
|	NULL
ERK-1	NULL
z	NULL
se	NULL
cue	NULL
cage	NULL
sme	NULL
.	NULL

|	NULL
«	NULL
f-	NULL
c-Jun	NULL
«	NULL
ll	NULL
-	NULL
JNK-1	NULL
anti-CD3	NULL
(	NULL
10	NULL
g/m	NULL
!	NULL
)	NULL

+	NULL
E	NULL
Cu	NULL
a	NULL
-	NULL
1	NULL
)	NULL
:	NULL
a	NULL
$	NULL
PV-1	NULL
anti-CD28	NULL
(	NULL
ug/ml	NULL
)	NULL
:	NULL
_	NULL
,	NULL
Z	NULL
E	NULL
E	NULL
0	NULL
01	NULL
1	NULL
5s	NULL
10	NULL
20	NULL
IP	NULL
:	NULL
anlNNK-1l	NULL
c	NULL
Me	NULL
Ames	NULL
ava	NULL
Are	NULL
dik	NULL
»	NULL
|*	NULL
'	NULL
``	NULL
``	NULL
“	NULL
``	NULL
B|	NULL
mm	NULL
o-	NULL
woe	NULL
ww	NULL
gos	NULL
om	NULL
muy	NULL
con	NULL
|	NULL
@	NULL
-	NULL
JNK1	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
ERK-1	NULL
activity	NULL
stimulated	NULL
by	NULL
anti-CD3	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
result	NULL
was	NULL
obtained	NULL
for	NULL
JNK-1	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
p38	NULL
MAPK	NULL
was	NULL
optimally	NULL
activated	NULL
by	NULL
anti-CD28	NULL
at	NULL
concentrations	NULL
of	NULL
1-5	NULL
ug/ml	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
kinetics	NULL
of	NULL
ERK-1	NULL
and	NULL
JNK-1	NULL
activation	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
p38	NULL
MAPK	NULL
,	NULL
the	NULL
time	NULL
courses	NULL
of	NULL
activation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
induced	NULL
by	NULL
coligation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
were	NULL
determined	NULL
.	NULL

ERK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
activity	NULL
peaked	NULL
at	NULL
15	NULL
and	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
,	NULL
but	NULL
JNK-1	NULL
was	NULL
not	NULL
activated	NULL
throughout	NULL
the	NULL
entire	NULL
time	NULL
course	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
of	NULL
CD28	NULL
costimulation	NULL
was	NULL
also	NULL
analyzed	NULL
by	NULL
pretreating	NULL
thymocytes	NULL
with	NULL
an	NULL
optimum	NULL
concentration	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
plus	NULL
variable	NULL
concentrations	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
0.1-20	NULL
ug/ml	NULL
)	NULL
.	NULL

ERK-1	NULL
activation	NULL
was	NULL
gradually	NULL
enhanced	NULL
by	NULL
addition	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
anti-CD3	NULL
,	NULL
with	NULL
maximal	NULL
activation	NULL
observed	NULL
at	NULL
10	NULL
and	NULL
20	NULL
ug/ml	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
p38	NULL
MAPK	NULL
activity	NULL
was	NULL
elevated	NULL
by	NULL
increasing	NULL
concentrations	NULL
of	NULL
anti-CD3	NULL
and	NULL
was	NULL
evident	NULL
even	NULL
at	NULL
very	NULL
low	NULL
concentrations	NULL
(	NULL
0.1	NULL
ug/ml	NULL
!	NULL
)	NULL

of	NULL
added	NULL
anti-CD3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
JNK-1	NULL
was	NULL
not	NULL
activated	NULL
significantly	NULL
at	NULL
any	NULL
concentration	NULL
of	NULL
added	NULL
anti-CD3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
detect	NULL
JNK-1	NULL
activation	NULL
upon	NULL
CD3/	NULL
CD28	NULL
coligation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
reactivity	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
with	NULL
the	NULL
appropriate	NULL
CD28	NULL
epitope	NULL
required	NULL
for	NULL
JNK-1	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
use	NULL
of	NULL
another	NULL
anti-CD28	NULL
mAb	NULL
,	NULL
PV-1	NULL
,	NULL
which	NULL
recognizes	NULL
a	NULL
different	NULL
epitope	NULL
than	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
as	NULL
determined	NULL
by	NULL
a	NULL
competitive	NULL
binding	NULL
assay	NULL
(	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
JNK-1	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
PMA	NULL
activated	NULL
JNK-1	NULL
in	NULL
a	NULL
positive	NULL
control	NULL
sample	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
TCR-	NULL
and	NULL
CD28-mediated	NULL
signaling	NULL
pathways	NULL
,	NULL
and	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
CD28	NULL
costimulation	NULL
of	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
requires	NULL
costimulation	NULL
by	NULL
Ca	NULL
``	NULL
*	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
In	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
Ca**	NULL
ionophore	NULL
A23187	NULL
(	NULL
500	NULL
ng/	NULL
ml	NULL
)	NULL
activates	NULL
p38	NULL
MAPK	NULL
,	NULL
synergizes	NULL
with	NULL
PMA	NULL
to	NULL
further	NULL
enhance	NULL
p38	NULL
MAPK	NULL
activation	NULL
,	NULL
and	NULL
inhibits	NULL
JNK-1	NULL
activity	NULL
induced	NULL
by	NULL
PMA	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
relationship	NULL
of	NULL
these	NULL
findings	NULL
to	NULL
the	NULL
dose	NULL
of	NULL
A23187	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
a	NULL
range	NULL
of	NULL
concentrations	NULL
(	NULL
15-1000	NULL
ng/m	NULL
!	NULL
)	NULL

of	NULL
A23187	NULL
.	NULL

ERK-1	NULL
activity	NULL
was	NULL
not	NULL
enhanced	NULL
at	NULL
any	NULL
of	NULL
the	NULL
concentrations	NULL
of	NULL
A23187	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

INK-1	NULL
activity	NULL
was	NULL
inhibited	NULL
significantly	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
when	NULL
A23187	NULL
was	NULL
added	NULL
to	NULL
PMA	NULL
,	NULL
and	NULL
concentrations	NULL
of	NULL
>	NULL
125	NULL
ng/ml	NULL
A23187	NULL
abolished	NULL
virtually	NULL
all	NULL
detectable	NULL
JNK-1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
this	NULL
inhibition	NULL
of	NULL
JNK	NULL
by	NULL
A23187	NULL
was	NULL
not	NULL
due	NULL
to	NULL
different	NULL
kinetics	NULL
of	NULL
JNK	NULL
activation	NULL
induced	NULL
by	NULL
PMA/A23187	NULL
versus	NULL
PMA	NULL
alone	NULL
.	NULL

PMA-induced	NULL
JNK	NULL
activation	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
after	NULL
stimulation	NULL
for	NULL
15	NULL
min	NULL
,	NULL
whereas	NULL
little	NULL
or	NULL
no	NULL
activation	NULL
of	NULL
JNK	NULL
was	NULL
induced	NULL
by	NULL
PMA/A23187	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p38	NULL
MAPK	NULL
activity	NULL
was	NULL
enhanced	NULL
upon	NULL
exposure	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
to	NULL
increasing	NULL
doses	NULL
of	NULL
A23187	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
60	NULL
ng/ml	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
latter	NULL
findings	NULL
on	NULL
induced	NULL
p38	NULL
MAPK	NULL
activity	NULL
correlate	NULL
closely	NULL
with	NULL
our	NULL
observations	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
proliferation	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
by	NULL
PMA	NULL
and	NULL
variable	NULL
amounts	NULL
of	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
inhibition	NULL
of	NULL
PMA-induced	NULL
JNK	NULL
activation	NULL
by	NULL
A23187	NULL
suggests	NULL
that	NULL
Ca**	NULL
``	NULL
ionophore	NULL
may	NULL
activate	NULL
some	NULL
JNK-specific	NULL
MAPK	NULL
phosphatases	NULL
that	NULL
inactivate	NULL
JNK	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
the	NULL
effect	NULL
of	NULL
Ca**	NULL
on	NULL
p38	NULL
MAPK	NULL
activation	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
CsA	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
,	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
inhibit	NULL
the	NULL
calcium-dependent	NULL
phosphatase	NULL
calcineurin	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
previous	NULL
observation	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti-CD28	NULL
alone	NULL
resulted	NULL
in	NULL
only	NULL
modest	NULL
p38	NULL
MAPK	NULL
activation	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
was	NULL
activated	NULL
synergistically	NULL
by	NULL
either	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
PMA/A23187	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
induced	NULL
p38	NULL
MAPK	NULL
activities	NULL
were	NULL
inhibited	NULL
appreciably	NULL
by	NULL
CsA	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
PMA-	NULL
and	NULL
CD28-induced	NULL
p38	NULL
MAPK	NULL
activation	NULL
was	NULL
CsA	NULL
resistant	NULL
.	NULL

Interestingly	NULL
,	NULL
inhibition	NULL
of	NULL
PMA/Ca®*	NULL
ionophore-induced	NULL
p38	NULL
MAPK	NULL
activity	NULL
by	NULL
CsA	NULL
pretreatment	NULL
occurred	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
induced	NULL
only	NULL
by	NULL
PMA	NULL
,	NULL
and	NULL
this	NULL
PMA-induced	NULL
JNK	NULL
activity	NULL
was	NULL
inhibited	NULL
by	NULL
Ca**	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CsA	NULL
did	NULL
not	NULL
further	NULL
inhibit	NULL
JNK	NULL
activity	NULL
induced	NULL
by	NULL
PMA/Ca®*	NULL
ionophore	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
optimal	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
requires	NULL
two	NULL
signals	NULL
,	NULL
one	NULL
provided	NULL
by	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
or	NULL
PMA	NULL
and	NULL
another	NULL
provided	NULL
by	NULL
CD28	NULL
or	NULL
Ca**	NULL
ionophore	NULL
.	NULL

Different	NULL
requirements	NULL
for	NULL
JNK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
proliferating	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
primary	NULL
T	NULL
cells	NULL
JNK	NULL
activation	NULL
requires	NULL
two	NULL
signals	NULL
generated	NULL
by	NULL
the	NULL
TCR	NULL
and	NULL
CD28	NULL
or	NULL
PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
mouse	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
p38	NULL
MAPK	NULL
activation	NULL
has	NULL
the	NULL
same	NULL
requirements	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
activation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
response	NULL
to	NULL
ligation	NULL
of	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
CD3	NULL
plus	NULL
CD28	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
PMA	NULL
plus	NULL
Ca**	NULL
ionophore	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

ERK-1	NULL
activation	NULL
was	NULL
only	NULL
seen	NULL
3823	NULL
A	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

+	NULL
A23187	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

NS	NULL
0	NULL
15	NULL
30	NULL
60	NULL
125	NULL
250	NULL
500	NULL
1000	NULL
IP	NULL
:	NULL
[	NULL
comme	NULL
cames	NULL
cams	NULL
comum	NULL
om	NULL
mmm	NULL
comm	NULL
m	NULL
|	NULL
«	NULL
t-	NULL
NLD	NULL
anti-ERK-1	NULL
IB	NULL
|	NULL
~~	NULL
-one	NULL
wattle	NULL
moe	NULL
ole	NULL
me	NULL
wom	NULL
~-	NULL
_-	NULL
|	NULL
<	NULL
g-ERK-1	NULL
IP	NULL
:	NULL
«	NULL
<	NULL
a	NULL
ami-Jnml	NULL
e	NULL
om	NULL
e	NULL
|-l—	NULL
:	NULL
-Jun	NULL
1B	NULL
-——_-—1	NULL
!	NULL

21+JNK-l	NULL
IP	NULL
:	NULL
s	NULL
bpss	NULL
-o	NULL
came	NULL
Tt	NULL
Ts	NULL
Tie	NULL
wom	NULL
wam	NULL
Blo	NULL
mam	NULL
«	NULL
o-	NULL
mm	NULL
cme	NULL
sam	NULL
om	NULL
mee	NULL
=~	NULL
|	NULL
4-538	NULL
B	NULL
PMA	NULL
PMA+A23187	NULL
min	NULL
:	NULL
0	NULL
1	NULL
§	NULL
10	NULL
15	NULL
1	NULL
§	NULL
10	NULL
_	NULL
15	NULL
JNKI	NULL
.	NULL

.	NULL

<	NULL
«	NULL
#	NULL
-	NULL
c-Jun	NULL
C	NULL
®	NULL
£5	NULL
2	NULL
o	NULL
g	NULL
``	NULL
£	NULL
E	NULL
£2	NULL
.	NULL

2	NULL
§	NULL
f	NULL
§	NULL
g	NULL
g	NULL
g	NULL
§	NULL
o	NULL
5	NULL
2	NULL
8	NULL
s	NULL
§	NULL
§	NULL
§	NULL
3	NULL
Stimuli	NULL
(	NULL
PMA/A23187	NULL
,	NULL
ng/m	NULL
!	NULL
)	NULL

D	NULL
CsA	NULL
:	NULL
=	NULL
=	NULL
+	NULL
-	NULL
+	NULL
=	NULL
+	NULL
~	NULL
+	NULL
anti-CD3	NULL
:	NULL
-	NULL
+	NULL
e	NULL
+0	NULL
+	NULL
o	NULL
>	NULL
=	NULL
anti-CD28	NULL
:	NULL
=	NULL
-	NULL
+0	NULL
+	NULL
+	NULL
+	NULL
-	NULL
s	NULL
PMA	NULL
:	NULL
_-	NULL
~	NULL
-	NULL
>	NULL
=_	NULL
>	NULL
+	NULL
+	NULL
Ip	NULL
:	NULL
LJ	NULL
anti-p38	NULL
Wht	NULL
ware	NULL
ms.	NULL
dle	NULL
arm	NULL
-|-'-—ATF	NULL
2	NULL
JNK	NULL
|	NULL
Cavan	NULL
)	NULL
<	NULL
4-	NULL
c-jun	NULL
CsA	NULL
(	NULL
ng/mi	NULL
)	NULL
:	NULL
0	NULL
©	NULL
500	NULL
0	NULL
100	NULL
250	NULL
500	NULL
PMA	NULL
:	NULL
=-	NULL
0	NULL
40	NULL
40	NULL
40	NULL
40	NULL
+0	NULL
o+	NULL
#	NULL
AZ3M87	NULL
:	NULL
0	NULL
to	NULL
to	NULL
co	NULL
+	NULL
+	NULL
+	NULL
+	NULL
IP	NULL
:	NULL
.	NULL

FIGURE	NULL
3	NULL
.	NULL

PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
synergistically	NULL
activate	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
ERK-1	NULL
or	NULL
JNK-1	NULL
.	NULL

A	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
variable	NULL
(	NULL
0-1000	NULL
ng/m	NULL
!	NULL
)	NULL

concentrations	NULL
of	NULL
A23187	NULL
in	NULL
DMSO	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
activities	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
were	NULL
detected	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

B	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
either	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
or	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
500	NULL
ng/tl	NULL
)	NULL
for	NULL
1	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
a	NULL
solid-phase	NULL
kinase	NULL
assay	NULL
of	NULL
JNK	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

C	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10°/ml	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
incremental	NULL
concentrations	NULL
(	NULL
15-1000	NULL
ng/m	NULL
!	NULL
)	NULL

of	NULL
A23187	NULL
for	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
proliferation	NULL
was	NULL
determined	NULL
by	NULL
[	NULL
*HJthy-midine	NULL
incorporation	NULL
.	NULL

The	NULL
results	NULL
of	NULL
triplicate	NULL
cultures	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
.	NULL

D	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
pretreated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
CsA	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD28	NULL
,	NULL
anti-CD3	NULL
plus	NULL
CD28	NULL
,	NULL
or	NULL
PMA	NULL
.	NULL

Alternatively	NULL
,	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
CsA	NULL
(	NULL
0-500	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
A23187	NULL
.	NULL

p38	NULL
MAPK	NULL
activity	NULL
was	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
and	NULL
a	NULL
solid-phase	NULL
JNK	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

upon	NULL
anti-CD3	NULL
or	NULL
PMA	NULL
stimulation	NULL
,	NULL
and	NULL
no	NULL
further	NULL
augmentation	NULL
was	NULL
observed	NULL
upon	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
exposure	NULL
to	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

JINK-1	NULL
activation	NULL
required	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3824	NULL
COSTIMULATORY	NULL
ACTIVATION	NULL
OF	NULL
p38	NULL
MAPK	NULL
IN	NULL
PRIMARY	NULL
T	NULL
CELLS	NULL
A	NULL
Jurkat	NULL
T	NULL
Cells	NULL
anti-CD3	NULL
:	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
*	NULL
anti-CD28	NULL
:	NULL
=	NULL
=	NULL
+	NULL
+	NULL
#	NULL
PMA	NULL
:	NULL
-	NULL
-	NULL
-	NULL
e	NULL
+	NULL
A23187	NULL
:	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
+	NULL
6	NULL
--	NULL
-	NULL
BAL	NULL
|	NULL
*-*	NULL
ant-enc1	NULL
|	NULL
~*~	NULL
J	NULL
IP	NULL
:	NULL
-so	NULL
--	NULL
WID	NULL
|	NULL
4-cun	NULL
anti-JNK-1	NULL
FIGURE	NULL
4	NULL
.	NULL

Different	NULL
requirements	NULL
for	NULL
MAPK	NULL
IP	NULL
:	NULL
«	NULL
e	NULL
--	NULL
»	NULL
H	NULL
“	NULL
-	NULL
«	NULL
sll	NULL
-	NULL
ATF-2	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
anti-p38	NULL
10'/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
B	NULL
anti-CD28	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
csK	NULL
:	NULL
Jurkat	NULL
T	NULL
Cells	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
A23187	NULL
*	NULL
x	NULL
Z	NULL
L	NULL
#	NULL
L	NULL
i	NULL
ad	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
anti-CD3	NULL
:	NULL
+	NULL
+	NULL
+	NULL
=	NULL
=	NULL
=	NULL
=	NULL
immunoprecipitated	NULL
with	NULL
anti-ERK-1	NULL
,	NULL
anti-JNK-1	NULL
,	NULL
anti-CD28	NULL
:	NULL
=	NULL
+	NULL
+	NULL
~	NULL
=~	NULL
b	NULL
=	NULL
and	NULL
anti-p38	NULL
MAPK	NULL
polyclonal	NULL
Abs	NULL
,	NULL
respectively	NULL
.	NULL

PMA	NULL
:	NULL
*	NULL
*	NULL
=	NULL
*	NULL
+	NULL
+	NULL
+	NULL
In	NULL
vitro	NULL
kinase	NULL
assays	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
A23187	NULL
:	NULL
~	NULL
~	NULL
~	NULL
~	NULL
~	NULL
*	NULL
+	NULL
MAPK	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T	NULL
IP	NULL
:	NULL
aap	NULL
a	NULL
»	NULL
Ger	NULL
Gp	NULL
--	NULL
MBP	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
in	NULL
A	NULL
,	NULL
but	NULL
were	NULL
either	NULL
pre-	NULL
anti-ERK-1	NULL
~-	NULL
mi	NULL
treated	NULL
or	NULL
not	NULL
with	NULL
CsA	NULL
(	NULL
500	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
before	NULL
stimulation	NULL
.	NULL

C	NULL
,	NULL
Proliferating	NULL
T	NULL
cells	NULL
IP	NULL
:	NULL
h	NULL
dine	NULL
|	NULL
Heoup	NULL
-	NULL
h	NULL
-	NULL
#	NULL
-	NULL
c-Jun	NULL
were	NULL
stimulated	NULL
with	NULL
Nig	NULL
,	NULL
anti-CD3	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
anti-	NULL
anti-JNK-1	NULL
q	NULL
-	NULL
commin	NULL
.	NULL

CD28	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
anti-CD3/CD28	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activities	NULL
IP	NULL
:	NULL
:	NULL
>	NULL
«	NULL
am	NULL
»	NULL
mmc	NULL
D	NULL
-r	NULL
(	NULL
<	NULL
s4-	NULL
ATT	NULL
-	NULL
>	NULL
were	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
anti-p38	NULL
for	NULL
protein	NULL
abundance	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
C	NULL
F	NULL
T	NULL
MAPK	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
exper-	NULL
s	NULL
R	NULL
Prol	NULL
IfEI'aﬂl'lg	NULL
anti-CD3	NULL
:	NULL
=	NULL
+	NULL
+	NULL
Cells	NULL
iments	NULL
are	NULL
shown	NULL
.	NULL

anti-CD28	NULL
:	NULL
5	NULL
s	NULL
+	NULL
+	NULL
IP	NULL
:	NULL
«	NULL
<	NULL
amime	NULL
p	NULL
«	NULL
l	NULL
anti-ERK-1	NULL
l	NULL
l	NULL
Mel	NULL
19	NULL
_	NULL
ose	NULL
_	NULL
_	NULL
|	NULL
<	NULL
-ERK-1	NULL
IP	NULL
:	NULL
unis	NULL
|	NULL
«	NULL
wom	NULL
»	NULL
«	NULL
meme	NULL
emmm	NULL
|	NULL
4-	NULL
c-un	NULL
iB	NULL
|	NULL
«	NULL
=-	NULL
«	NULL
-	NULL
«	NULL
-o	NULL
doin	NULL
aro	NULL
|	NULL
«	NULL
4-	NULL
JNK1	NULL
IP	NULL
:	NULL
antip38	NULL
-	NULL
|______	NULL
--	NULL
-	NULL
_	NULL
-=-	NULL
tM	NULL
|	NULL
<	NULL
-	NULL
Atr-2	NULL
CD3/CD28	NULL
coligation	NULL
.	NULL

PMA	NULL
induced	NULL
modest	NULL
JNK-1	NULL
activation	NULL
,	NULL
which	NULL
was	NULL
significantly	NULL
enhanced	NULL
by	NULL
PMA/A23187	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
anti-CD3	NULL
or	NULL
PMA	NULL
weakly	NULL
activated	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
full	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
required	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
PMA/Ca*	NULL
``	NULL
ionophore	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Ca**/calcineurin	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
after	NULL
a	NULL
15-min	NULL
incubation	NULL
with	NULL
CsA	NULL
(	NULL
500	NULL
ng/m1	NULL
)	NULL
.	NULL

CsA	NULL
did	NULL
not	NULL
inhibit	NULL
ERK-1	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
CD3/CD28	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
PMA/Ca2	NULL
*	NULL
ionophore	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
of	NULL
JNK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
induced	NULL
by	NULL
either	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
PMA/A23187	NULL
was	NULL
markedly	NULL
reduced	NULL
.	NULL

Notably	NULL
,	NULL
activation	NULL
of	NULL
JNK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
induced	NULL
by	NULL
PMA	NULL
was	NULL
insensitive	NULL
to	NULL
CsA	NULL
pretreatment	NULL
.	NULL

These	NULL
data	NULL
are	NULL
the	NULL
first	NULL
to	NULL
indicate	NULL
that	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
also	NULL
requires	NULL
two	NULL
signals	NULL
generated	NULL
by	NULL
TCR/CD28	NULL
or	NULL
PMA/Ca**	NULL
ionophore	NULL
signaling	NULL
.	NULL

To	NULL
obtain	NULL
additional	NULL
evidence	NULL
that	NULL
the	NULL
requirement	NULL
for	NULL
MAPK	NULL
activation	NULL
differs	NULL
between	NULL
T	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
activation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
or	NULL
CD28	NULL
stimulation	NULL
,	NULL
or	NULL
both	NULL
,	NULL
in	NULL
proliferating	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

B6	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
first	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
IL-2	NULL
for	NULL
48	NULL
h	NULL
and	NULL
then	NULL
expanded	NULL
in	NULL
medium	NULL
containing	NULL
IL-2	NULL
for	NULL
4	NULL
days	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
noted	NULL
that	NULL
,	NULL
although	NULL
the	NULL
cells	NULL
were	NULL
proliferating	NULL
,	NULL
about	NULL
30-40	NULL
%	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
nonviable	NULL
at	NULL
the	NULL
time	NULL
of	NULL
harvest	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
re-covered	NULL
,	NULL
stimulated	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
reports	NULL
for	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
,	NULL
TCR	NULL
stimulation	NULL
induced	NULL
full	NULL
ERK-1	NULL
activation	NULL
without	NULL
the	NULL
requirement	NULL
of	NULL
CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
whereas	NULL
optimal	NULL
p38	NULL
MAPK	NULL
activation	NULL
required	NULL
TCR/CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
JINK-1	NULL
was	NULL
modestly	NULL
activated	NULL
by	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
but	NULL
no	NULL
synergistic	NULL
activation	NULL
of	NULL
JNK-1	NULL
occurred	NULL
upon	NULL
CD3/CD28	NULL
coligation	NULL
.	NULL

JNK-1	NULL
was	NULL
fully	NULL
activated	NULL
,	NULL
however	NULL
,	NULL
by	NULL
CD28	NULL
ligation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
proliferating	NULL
mouse	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
differ	NULL
in	NULL
terms	NULL
of	NULL
their	NULL
requirements	NULL
for	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activation	NULL
.	NULL

p38	NULL
MAPK	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
The	NULL
requirement	NULL
of	NULL
p38	NULL
MAPK	NULL
activation	NULL
for	NULL
T	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
was	NULL
investigated	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
J	NULL
>	NULL
3825	NULL
FIGURE	NULL
5	NULL
.	NULL

A	NULL
p38	NULL
MAPK	NULL
-	NULL
inhibitor	NULL
,	NULL
$	NULL
B203580	NULL
,	NULL
suppresses	NULL
T	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
CD3	NULL
and	NULL
CD3/CD28	NULL
ligation	NULL
.	NULL

A	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
variable	NULL
concentrations	NULL
(	NULL
0-100	NULL
pM	NULL
)	NULL
of	NULL
$	NULL
B203580	NULL
or	NULL
DMSO	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
(	NULL
1	NULL
ug/	NULL
20	NULL
ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-CD28	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

Cell	NULL
proliferation	NULL
was	NULL
determined	NULL
by	NULL
incorporation	NULL
.	NULL

The	NULL
results	NULL
of	NULL
triplicate	NULL
cultures	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
.	NULL

B	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
105/ml	NULL
)	NULL
were	NULL
pretreated	NULL
with	NULL
either	NULL
$	NULL
B203580	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
in	NULL
DMSO	NULL
or	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
DMSO	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

Cell	NULL
death	NULL
was	NULL
detected	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow-cytometric	NULL
analysis	NULL
.	NULL

C	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/ml	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
$	NULL
B203580	NULL
(	NULL
1-100	NULL
uM	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
.	NULL

p38	NULL
MAPK	NULL
activity	NULL
was	NULL
detected	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

MAPKAP	NULL
kinase-2	NULL
activity	NULL
was	NULL
performed	NULL
using	NULL
recombinant	NULL
murine	NULL
hsp25	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Note	NULL
that	NULL
SB203580	NULL
was	NULL
present	NULL
during	NULL
the	NULL
immunoprecipitation	NULL
and	NULL
kinase	NULL
reactions	NULL
.	NULL

D	NULL
,	NULL
Splenic	NULL
T	NULL
cells	NULL
(	NULL
10'/m	NULL
!	NULL

l	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
$	NULL
B203580	NULL
(	NULL
1-100	NULL
uM	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
alternatively	NULL
with	NULL
PMA	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
.	NULL

ERK-1	NULL
activity	NULL
was	NULL
assayed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
and	NULL
a	NULL
solid	NULL
JNK	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

ERK-1	NULL
abundance	NULL
was	NULL
detected	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
two	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

80	NULL
[	NULL
BH	NULL
]	NULL
-Thymidine	NULL
(	NULL
cpm	NULL
x103	NULL
)	NULL
$	NULL
0	NULL
$	NULL
B203580	NULL
Concentration	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
D	NULL
$	NULL
B203580	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
,	NULL
and	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
complete	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
.	NULL

$	NULL
B203580	NULL
inhibited	NULL
T	NULL
cell	NULL
proliferation	NULL
significantly	NULL
and	NULL
blocked	NULL
T	NULL
cell	NULL
proliferation	NULL
completely	NULL
at	NULL
concentrations	NULL
of	NULL
10	NULL
and	NULL
100	NULL
uM	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
results	NULL
from	NULL
SB203580-induced	NULL
cell	NULL
toxicity	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
viable	NULL
T	NULL
cells	NULL
to	NULL
survive	NULL
after	NULL
exposure	NULL
to	NULL
$	NULL
B203580	NULL
was	NULL
measured	NULL
.	NULL

As	NULL
evaluated	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
,	NULL
we	NULL
found	NULL
that	NULL
SB203580	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
completely	NULL
inhibited	NULL
T	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
SB203580	NULL
(	NULL
40-100	NULL
uM	NULL
)	NULL
also	NULL
significantly	NULL
inhibited	NULL
TCR-induced	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
DO11.10	NULL
murine	NULL
T	NULL
cell	NULL
hybridoma	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
ability	NULL
of	NULL
SB203580	NULL
to	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
any	NULL
nonspecific	NULL
DMSO	NULL
solvent	NULL
effects	NULL
,	NULL
as	NULL
pretreatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
DMSO	NULL
alone	NULL
failed	NULL
to	NULL
inhibit	NULL
p38	NULL
MAPK	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
ability	NULL
of	NULL
$	NULL
B203580	NULL
to	NULL
block	NULL
T	NULL
cell	NULL
proliferation	NULL
correlated	NULL
closely	NULL
with	NULL
its	NULL
capacity	NULL
to	NULL
inhibit	NULL
p38	NULL
MAPK	NULL
activity	NULL
,	NULL
as	NULL
activities	NULL
of	NULL
p38	NULL
MAPK	NULL
and	NULL
its	NULL
downstream	NULL
target	NULL
MAPKAP	NULL
kinase-2	NULL
induced	NULL
by	NULL
stimulation	NULL
with	NULL
either	NULL
anti-CD3	NULL
and	NULL
anti-CD3/CD28	NULL
were	NULL
greatly	NULL
diminished	NULL
by	NULL
$	NULL
B203580	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
since	NULL
SB203580	NULL
reversibly	NULL
binds	NULL
to	NULL
the	NULL
ATP	NULL
binding	NULL
site	NULL
of	NULL
p38	NULL
MAPK	NULL
,	NULL
$	NULL
B203580	NULL
was	NULL
present	NULL
continuously	NULL
during	NULL
the	NULL
kinase	NULL
assays	NULL
.	NULL

$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
:	NULL
0	NULL
0	NULL
1	NULL
10	NULL
100	NULL
0	NULL
1	NULL
IP	NULL
:	NULL
|	NULL
anti-MAPKAPK-2	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
:	NULL
0	NULL
0	NULL
1	NULL
10	NULL
-	NULL
&	NULL
anti-CD3	NULL
anti-CD3/CD28	NULL
3	NULL
Cell	NULL
Death	NULL
(	NULL
%	NULL
)	NULL
$	NULL
10	NULL
100	NULL
{	NULL
LCD	NULL
303553	NULL
,	NULL
Ng	NULL
anti-col	NULL
?	NULL

an	NULL
Se	NULL
10	NULL
100	NULL
anti-CD3	NULL
:	NULL
-/	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
anti-CD28	NULL
:	NULL
-0	NULL
>	NULL
-	NULL
=	NULL
=	NULL
+	NULL
+	NULL
IP	NULL
:	NULL
|	NULL
ws	NULL
ste	NULL
4	NULL
anti-p38	NULL
IB	NULL
|	NULL
eal	NULL
|+	NULL
ATF-2	NULL
___	NULL
__|	NULL
#	NULL
pss	NULL
Slt	NULL
Hitec	NULL
wass	NULL
|-l—	NULL
HSP25	NULL
[	NULL
_	NULL
IB	NULL
[	NULL
__	NULL
__	NULL
_-_	NULL
-	NULL
<	NULL
_-_	NULL
-~	NULL
_-	NULL
--	NULL
-	NULL
]	NULL
@	NULL
-	NULL
MAPKAPK-2	NULL
100	NULL
0	NULL
1	NULL
10	NULL
100	NULL
anti-CD3	NULL
:	NULL
-o	NULL
g	NULL
0400+	NULL
+	NULL
+0	NULL
+	NULL
+	NULL
+	NULL
anti-CD28	NULL
:	NULL
«	NULL
00k	NULL
00k	NULL
o	NULL
>	NULL
-o	NULL
t	NULL
%	NULL
0	NULL
4	NULL
+	NULL
IP	NULL
:	NULL
anti-ERK-1	NULL
l	NULL
m	NULL
an	NULL
yo	NULL
us	NULL
to	NULL
--	NULL
ap	NULL
-*	NULL
|+	NULL
MBP	NULL
|Bi	NULL
___—_———-__|+EHK-1	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
:	NULL
0	NULL
0	NULL
1	NULL
10	NULL
_	NULL
100	NULL
PMA	NULL
:	NULL
__-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
At	NULL
concentrations	NULL
of	NULL
>	NULL
10	NULL
uM	NULL
,	NULL
the	NULL
SB203580	NULL
inhibitor	NULL
may	NULL
lose	NULL
its	NULL
selectivity	NULL
and	NULL
also	NULL
block	NULL
and	NULL
(	NULL
44	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
inhibitor	NULL
,	NULL
purified	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
0-100	NULL
uM	NULL
)	NULL
,	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
,	NULL
and	NULL
lysed	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
either	NULL
reacted	NULL
with	NULL
GST-c-Jun	NULL
precoupled	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
or	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-anti-ERK-1	NULL
Ab	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SB203580	NULL
.	NULL

The	NULL
immobilized	NULL
kinases	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
substrates	NULL
and	NULL
$	NULL
B203580	NULL
(	NULL
0-100	NULL
M	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

ERK-1	NULL
and	NULL
JNK	NULL
activities	NULL
remained	NULL
unaffected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
$	NULL
B203580	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

$	NULL
B203580	NULL
inhibits	NULL
cytokine	NULL
secretions	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
We	NULL
next	NULL
investigated	NULL
whether	NULL
$	NULL
B203580	NULL
inhibits	NULL
cytokine	NULL
secretions	NULL
induced	NULL
by	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
stimulation	NULL
of	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
either	NULL
different	NULL
concentrations	NULL
of	NULL
S	NULL
$	NULL
B203580	NULL
in	NULL
DMSO	NULL
or	NULL
equivalent	NULL
amounts	NULL
of	NULL
DMSO	NULL
as	NULL
control	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
for	NULL
quantification	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
by	NULL
ELISA	NULL
.	NULL

Interestingly	NULL
,	NULL
$	NULL
B203580	NULL
inhibited	NULL
T	NULL
cell	NULL
secretion	NULL
of	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
induced	NULL
by	NULL
either	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
stimulation	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Since	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
cytokine	NULL
secretion	NULL
by	NULL
$	NULL
B203580	NULL
does	NULL
not	NULL
result	NULL
from	NULL
cell	NULL
death	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3826	NULL
COSTIMULATORY	NULL
ACTIVATION	NULL
OF	NULL
p38	NULL
MAPK	NULL
IN	NULL
PRIMARY	NULL
T	NULL
CELLS	NULL
A	NULL
$	NULL
B203580	NULL
:	NULL
*	NULL
*	NULL
*	NULL
*	NULL
*	NULL
anti-CD3/CD28	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
5	NULL
5	NULL
15	NULL
15	NULL
co	NULL
Tis	NULL
aa	NULL
Dis	NULL
Stes	NULL
4g	NULL
ATF	NULL
2	NULL
$	NULL
B203580	NULL
:	NULL
=	NULL
=	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
anti-CD3/CD28	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
§	NULL
§	NULL
15	NULL
15	NULL
PMA	NULL
PMA	NULL
N	NULL
ine	NULL
--	NULL
Tedi	NULL
-	NULL
--	NULL
ﬂ	NULL
c-Jun	NULL
$	NULL
B203580	NULL
:	NULL
~	NULL
*	NULL
+	NULL
=	NULL
+	NULL
®	NULL
+	NULL
anti-CD3	NULL
:	NULL
=	NULL
+	NULL
+	NULL
+	NULL
+	NULL
£	NULL
anti-CD28	NULL
:	NULL
*	NULL
*	NULL
=	NULL
+	NULL
+	NULL
PMA	NULL
:	NULL
-	NULL
=	NULL
=	NULL
=	NULL
=	NULL
+	NULL
war	NULL
yoo	NULL
I*	NULL
U6	NULL
¥	NULL
r	NULL
:	NULL
|+	NULL
t-Fos	NULL
=	NULL
.	NULL

.	NULL

(	NULL
Wp	NULL
-	NULL
CP	NULL
--	NULL
am	NULL
WM	NULL
|	NULL
«	NULL
i-	NULL
c-Jun	NULL
sm	NULL
«	NULL
a	NULL
B0	NULL
--	NULL
te	NULL
#	NULL
A	NULL
|	NULL
<	NULL
:	NULL
cms	NULL
C	NULL
CHX	NULL
:	NULL
-	NULL
-	NULL
=	NULL
anti-CD3	NULL
:	NULL
=	NULL
+	NULL
anti-CD28	NULL
:	NULL
+	NULL
+	NULL
we	NULL
Teag	NULL
ar	NULL
«	NULL
all-	NULL
c-Jun	NULL
A	NULL
1200	NULL
25000	NULL
g	NULL
co	NULL
A	NULL
``	NULL
ses	NULL
o	NULL
G	NULL
seo	NULL
-	NULL
20000	NULL
3	NULL
aly	NULL
|	NULL
o	NULL
=	NULL
o	NULL
®	NULL
720	NULL
15000	NULL
%	NULL
a	NULL
com	NULL
bs	NULL
E	NULL
a8so|l-	NULL
10000	NULL
M	NULL
B	NULL
<	NULL
39	NULL
I	NULL
§	NULL
240	NULL
e	NULL
~	NULL
his	NULL
0	NULL
0	NULL
=-Ns	NULL
0	NULL
1	NULL
10	NULL
50	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
B	NULL
120000	NULL
&	NULL
£3	NULL
|	NULL
a	NULL
a	NULL
0	NULL
100000	NULL
9	NULL
€	NULL
3	NULL
£	NULL
a	NULL
sooo0	NULL
Q	NULL
§	NULL
&	NULL
€	NULL
;	NULL
0000	NULL
|	NULL
&	NULL
fed	NULL
=	NULL
&	NULL
40000	NULL
E	NULL
i	NULL
8	NULL
é	NULL
20000	NULL
&	NULL
o	NULL
-	NULL
E	NULL
Ns	NULL
0	NULL
1	NULL
10	NULL
50	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
C	NULL
3000	NULL
2500	NULL
E	NULL
2000	NULL
£-o	NULL
CJanti-CD3	NULL
o	NULL
,	NULL
q	NULL
1500	NULL
W	NULL
=	NULL
!	NULL

1000	NULL
0	NULL
Ns	NULL
0	NULL
1	NULL
10	NULL
50	NULL
$	NULL
B203580	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

$	NULL
B203580	NULL
inhibits	NULL
cytokine	NULL
production	NULL
induced	NULL
by	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
different	NULL
concentrations	NULL
(	NULL
0-50	NULL
M	NULL
)	NULL
of	NULL
$	NULL
B203580	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
collected	NULL
after	NULL
48	NULL
h	NULL
,	NULL
and	NULL
were	NULL
assayed	NULL
for	NULL
their	NULL
concentrations	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
by	NULL
ELISA	NULL
using	NULL
a	NULL
double	NULL
ligand	NULL
method	NULL
.	NULL

The	NULL
results	NULL
of	NULL
triplicate	NULL
cultures	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

treatment	NULL
with	NULL
SB203580	NULL
induces	NULL
T	NULL
cells	NULL
to	NULL
become	NULL
functionally	NULL
unresponsive	NULL
.	NULL

$	NULL
B203580	NULL
represses	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
Our	NULL
data	NULL
suggest	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
of	NULL
TCR-	NULL
and	NULL
CD28-mediated	NULL
signaling	NULL
pathways	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
JNK	NULL
is	NULL
a	NULL
major	NULL
kinase	NULL
responsible	NULL
for	NULL
c-Jun	NULL
phosphorylation	NULL
and	NULL
p38	NULL
MAPK	NULL
can	NULL
not	NULL
phosphorylate	NULL
c-Jun	NULL
(	NULL
28	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
using	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
detect	NULL
c-Jun	NULL
phosphorylation	NULL
by	NULL
p38	NULL
MAPK	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and/or	NULL
ATF-2	NULL
is	NULL
required	NULL
for	NULL
c-Jun	NULL
gene	NULL
induction	NULL
,	NULL
we	NULL
analyzed	NULL
whether	NULL
blockade	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
results	NULL
in	NULL
the	NULL
reduced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
.	NULL

Thymocytes	NULL
were	NULL
preincubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
10	NULL
wM	NULL
SB203580	NULL
or	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
DMSO	NULL
as	NULL
control	NULL
,	NULL
and	NULL
were	NULL
then	NULL
either	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
for	NULL
5	NULL
and	NULL
15	NULL
min	NULL
,	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
blotted	NULL
with	NULL
anti-c-Jun	NULL
and	NULL
anti-ATF-2	NULL
mAbs	NULL
,	NULL
respectively	NULL
.	NULL

Phosphorylation	NULL
of	NULL
ATE-2	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
its	NULL
reduced	NULL
mobility	NULL
,	NULL
was	NULL
evident	NULL
FIGURE	NULL
7	NULL
.	NULL

$	NULL
B203580	NULL
inhibits	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
ATE-2	NULL
,	NULL
but	NULL
not	NULL
c-Fos	NULL
proteins	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Thymocytes	NULL
(	NULL
4	NULL
X	NULL
10'/ml	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
and	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
5	NULL
or	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
.	NULL

B	NULL
,	NULL
Thymocytes	NULL
were	NULL
preincubated	NULL
with	NULL
or	NULL
without	NULL
$	NULL
B203580	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
anti-CD3	NULL
,	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
,	NULL
or	NULL
PMA	NULL
.	NULL

C	NULL
,	NULL
Thymocytes	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
pretreated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
20	NULL
M	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Immunoblotting	NULL
was	NULL
conducted	NULL
using	NULL
anti-c-Fos	NULL
,	NULL
anti-c-Jun	NULL
,	NULL
and	NULL
anti-ATE-2	NULL
mAbs	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
chemoluminescence	NULL
.	NULL

Data	NULL
from	NULL
one	NULL
of	NULL
three	NULL
reproducible	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

after	NULL
5	NULL
and	NULL
15	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
and	NULL
these	NULL
mobility	NULL
shifts	NULL
were	NULL
significantly	NULL
inhibited	NULL
by	NULL
SB203580	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
c-Jun	NULL
phosphorylation	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
in	NULL
vitro	NULL
data	NULL
that	NULL
JNK	NULL
is	NULL
not	NULL
activated	NULL
upon	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
c-Jun	NULL
phosphorylation	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
anti-c-Jun	NULL
mAb	NULL
used	NULL
because	NULL
it	NULL
clearly	NULL
recognized	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
c-Jun	NULL
induced	NULL
by	NULL
PMA	NULL
stimulation	NULL
,	NULL
as	NULL
reported	NULL
(	NULL
45	NULL
)	NULL
.	NULL

SB203580	NULL
can	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
genes	NULL
by	NULL
diverse	NULL
stimuli	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
p38	NULL
MAPK	NULL
activity	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
our	NULL
finding	NULL
of	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
proteins	NULL
at	NULL
later	NULL
time	NULL
points	NULL
following	NULL
CD3/CD28	NULL
coligation	NULL
.	NULL

Interestingly	NULL
,	NULL
while	NULL
SB203580	NULL
pretreatment	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Fos	NULL
after	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

78	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
SB203580	NULL
pretreatment	NULL
significantly	NULL
reduced	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
induced	NULL
by	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
middle	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
was	NULL
enhanced	NULL
more	NULL
upon	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CD3/CD28	NULL
coligation	NULL
than	NULL
ligation	NULL
of	NULL
CD3	NULL
alone	NULL
.	NULL

The	NULL
nuclear	NULL
expression	NULL
of	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
stimulated	NULL
by	NULL
PMA	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
increase	NULL
of	NULL
c-Jun	NULL
expression	NULL
in	NULL
the	NULL
nucleus	NULL
was	NULL
due	NULL
to	NULL
enhancement	NULL
of	NULL
de	NULL
novo	NULL
c-Jun	NULL
protein	NULL
synthesis	NULL
,	NULL
the	NULL
sensitivity	NULL
of	NULL
c-Jun	NULL
nuclear	NULL
expression	NULL
to	NULL
cycloheximide	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
,	NULL
was	NULL
determined	NULL
.	NULL

Although	NULL
cycloheximide	NULL
may	NULL
stimulate	NULL
JNK	NULL
activity	NULL
,	NULL
pretreatment	NULL
of	NULL
thymocytes	NULL
with	NULL
20	NULL
uM	NULL
cycloheximide	NULL
virtually	NULL
abolished	NULL
the	NULL
increased	NULL
abundance	NULL
of	NULL
c-Jun	NULL
induced	NULL
by	NULL
CD3	NULL
and	NULL
CD3/CD28	NULL
ligation	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

The	NULL
blockade	NULL
of	NULL
c-Jun	NULL
expression	NULL
in	NULL
the	NULL
nucleus	NULL
by	NULL
SB203580	NULL
suggests	NULL
that	NULL
p38	NULL
MAPK	NULL
activity	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
protein	NULL
.	NULL

Discussion	NULL
Previous	NULL
studies	NULL
of	NULL
MAPK	NULL
activation	NULL
in	NULL
the	NULL
Jurkat	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
and	NULL
mouse	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
long-term	NULL
culture	NULL
suggested	NULL
that	NULL
JNK	NULL
activation	NULL
requires	NULL
costimulatory	NULL
signals	NULL
via	NULL
CD28	NULL
or	NULL
Ca**	NULL
ionophore	NULL
to	NULL
synergize	NULL
with	NULL
TCR-	NULL
or	NULL
PMA-driven	NULL
signals	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
pathways	NULL
of	NULL
activation	NULL
of	NULL
JNK	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
were	NULL
not	NULL
studied	NULL
extensively	NULL
and	NULL
are	NULL
less	NULL
well	NULL
understood	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
regulation	NULL
of	NULL
ERK-1	NULL
,	NULL
JNK-1	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activation	NULL
stimulated	NULL
by	NULL
TCR/CD28	NULL
or	NULL
PMA/Ca**	NULL
ionophore-mediated	NULL
signaling	NULL
in	NULL
naive	NULL
mouse	NULL
thymocytes	NULL
and	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
main	NULL
findings	NULL
are	NULL
:	NULL
1	NULL
)	NULL
CD3	NULL
or	NULL
CD28	NULL
stimulation	NULL
of	NULL
primary	NULL
naive	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
activates	NULL
p38	NULL
MAPK	NULL
,	NULL
;	NULL
2	NULL
)	NULL
CD3/CD28	NULL
coligation	NULL
synergistically	NULL
activates	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
;	NULL
3	NULL
)	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
is	NULL
Ca**	NULL
depen-dent	NULL
;	NULL
and	NULL
4	NULL
)	NULL
the	NULL
p38	NULL
MAPK	NULL
inhibitor	NULL
,	NULL
SB203580	NULL
,	NULL
blocks	NULL
CD3	NULL
and	NULL
CD3/CD28	NULL
ligation-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
as	NULL
well	NULL
as	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
CD28	NULL
costimulation	NULL
of	NULL
murine	NULL
primary	NULL
T	NULL
cells	NULL
and	NULL
may	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
CD28	NULL
and	NULL
PMA/Ca	NULL
``	NULL
*	NULL
iono-phore-triggered	NULL
signaling	NULL
stimulate	NULL
thymocytes	NULL
and	NULL
lymph	NULL
node	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
and	NULL
produce	NULL
IL-2	NULL
independently	NULL
of	NULL
JNK	NULL
activation	NULL
in	NULL
MKK-4-deficient	NULL
mice	NULL
(	NULL
37	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
MAPK	NULL
(	NULL
s	NULL
)	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
primary	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
impaired	NULL
CD28-mediated	NULL
IL-2	NULL
production	NULL
and	NULL
proliferation	NULL
by	NULL
T	NULL
cells	NULL
were	NULL
observed	NULL
in	NULL
these	NULL
mice	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Since	NULL
MKK-4	NULL
activates	NULL
both	NULL
JNK	NULL
and	NULL
p38	NULL
MAPK	NULL
(	NULL
5-9	NULL
)	NULL
,	NULL
this	NULL
impairment	NULL
might	NULL
be	NULL
attributed	NULL
to	NULL
defective	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
MKK-4-deficient	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
p38	NULL
MAPK	NULL
activity	NULL
was	NULL
not	NULL
analyzed	NULL
in	NULL
the	NULL
latter	NULL
report	NULL
.	NULL

Nonetheless	NULL
,	NULL
deficient	NULL
expression	NULL
of	NULL
MKK4	NULL
does	NULL
not	NULL
affect	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
$	NULL
B203580	NULL
inhibits	NULL
CD28-dependent	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

These	NULL
two	NULL
sets	NULL
of	NULL
evidence	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
p38	NULL
MAPK	NULL
in	NULL
the	NULL
costimulation	NULL
of	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
Con	NULL
A	NULL
and	NULL
PMA/	NULL
ionomycin	NULL
stimulation	NULL
is	NULL
normal	NULL
in	NULL
dominant-negative	NULL
p38	NULL
trans-genic	NULL
mice	NULL
,	NULL
TCR/CD28-mediated	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
p38	NULL
MAPK	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
different	NULL
stimuli	NULL
were	NULL
not	NULL
investigated	NULL
in	NULL
this	NULL
study	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Additional	NULL
studies	NULL
conducted	NULL
primarily	NULL
with	NULL
previously	NULL
activated	NULL
T	NULL
cells	NULL
have	NULL
shown	NULL
that	NULL
p38	NULL
MAPK	NULL
activation	NULL
is	NULL
inducible	NULL
by	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
CD3/CD28	NULL
stimulation	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
MAPK	NULL
activation	NULL
differs	NULL
between	NULL
primary	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
proliferating	NULL
preactivated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
proliferating	NULL
T	NULL
cells	NULL
,	NULL
while	NULL
ERK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
activity	NULL
are	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
primary	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
JNK-1	NULL
is	NULL
weakly	NULL
activated	NULL
by	NULL
CD3	NULL
stimulation	NULL
and	NULL
is	NULL
fully	NULL
activated	NULL
only	NULL
upon	NULL
CD28	NULL
stimulation	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
a	NULL
high	NULL
percentage	NULL
of	NULL
proliferating	NULL
T	NULL
cells	NULL
become	NULL
apoptotic	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
the	NULL
3827	NULL
continuous	NULL
exposure	NULL
to	NULL
IL-2	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p38	NULL
MAPK	NULL
and	NULL
JNK-1	NULL
activation	NULL
in	NULL
proliferating	NULL
T	NULL
cells	NULL
may	NULL
result	NULL
in	NULL
part	NULL
from	NULL
activa-tion-induced	NULL
apoptosis	NULL
.	NULL

The	NULL
requirements	NULL
for	NULL
p38	NULL
MAPK	NULL
and	NULL
JNK-1	NULL
activation	NULL
in	NULL
murine	NULL
primary	NULL
T	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
differ	NULL
from	NULL
those	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
frequently	NULL
used	NULL
to	NULL
identify	NULL
pathways	NULL
of	NULL
T	NULL
cell	NULL
signaling	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
optimal	NULL
activation	NULL
of	NULL
both	NULL
p38	NULL
MAPK	NULL
and	NULL
JNK-1	NULL
requires	NULL
TCR/CD28	NULL
coligation	NULL
or	NULL
PMA/Ca	NULL
``	NULL
*	NULL
ionophore	NULL
costimulation	NULL
.	NULL

In	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
stimulation	NULL
by	NULL
either	NULL
CD28	NULL
or	NULL
Ca**	NULL
ionophore	NULL
activates	NULL
p38	NULL
MAPK	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
can	NULL
be	NULL
activated	NULL
synergistically	NULL
by	NULL
CD3/CD28	NULL
coligation	NULL
or	NULL
PMA/Ca®*	NULL
ionophore	NULL
stimulation	NULL
.	NULL

Whereas	NULL
high	NULL
concentrations	NULL
of	NULL
Ca**	NULL
ionophore	NULL
inhibit	NULL
JINK-1	NULL
activity	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
these	NULL
same	NULL
concentrations	NULL
of	NULL
Ca**	NULL
ionophore	NULL
augment	NULL
p38	NULL
MAPK	NULL
activity	NULL
.	NULL

This	NULL
enhancement	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
correlates	NULL
closely	NULL
with	NULL
T	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
optimal	NULL
concentrations	NULL
of	NULL
PMA	NULL
and	NULL
Ca**	NULL
ionophore	NULL
.	NULL

Furthermore	NULL
,	NULL
CsA	NULL
inhibited	NULL
p38	NULL
MAPK	NULL
activation	NULL
by	NULL
anti-CD3	NULL
,	NULL
anti-CD3	NULL
plus	NULL
CD28	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
Ca**	NULL
ionophore	NULL
.	NULL

Although	NULL
the	NULL
levels	NULL
of	NULL
activation	NULL
of	NULL
ERK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
CD3-	NULL
or	NULL
CD3/CD28-stimulated	NULL
proliferating	NULL
and	NULL
naive	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
are	NULL
similar	NULL
,	NULL
JNK-1	NULL
is	NULL
fully	NULL
activated	NULL
by	NULL
CD28	NULL
ligation	NULL
alone	NULL
in	NULL
proliferating	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
requirements	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
JNK-1	NULL
and	NULL
p38	NULL
MAPK	NULL
differ	NULL
among	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
proliferating	NULL
T	NULL
cells	NULL
.	NULL

Such	NULL
differences	NULL
may	NULL
arise	NULL
from	NULL
the	NULL
stage	NULL
of	NULL
activation	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
are	NULL
transformed	NULL
activated	NULL
cells	NULL
in	NULL
continuous	NULL
growth	NULL
in	NULL
culture	NULL
,	NULL
and	NULL
these	NULL
cells	NULL
appear	NULL
to	NULL
differ	NULL
somewhat	NULL
in	NULL
their	NULL
signaling	NULL
pathways	NULL
from	NULL
fresh	NULL
isolated	NULL
primary	NULL
T	NULL
cells	NULL
that	NULL
presumably	NULL
consist	NULL
mainly	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
resting	NULL
state	NULL
.	NULL

As	NULL
JINK-1	NULL
activation	NULL
was	NULL
not	NULL
detected	NULL
after	NULL
CD3/CD28	NULL
costimulation	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
further	NULL
analyzed	NULL
the	NULL
reactivity	NULL
and	NULL
epitope	NULL
specificity	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
used	NULL
for	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

Costimulation	NULL
by	NULL
a	NULL
wide	NULL
concentration	NULL
range	NULL
of	NULL
this	NULL
mAb	NULL
plus	NULL
a	NULL
single	NULL
dose	NULL
of	NULL
anti-CD3	NULL
did	NULL
not	NULL
induce	NULL
JNK-1	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
optimum	NULL
conditions	NULL
of	NULL
CD3/CD28	NULL
costimulation	NULL
elicited	NULL
the	NULL
full	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
.	NULL

While	NULL
recent	NULL
studies	NULL
indicate	NULL
that	NULL
JINK-1	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
CD3/CD28	NULL
coligation	NULL
in	NULL
mouse	NULL
lymph	NULL
node	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
was	NULL
achievable	NULL
only	NULL
after	NULL
preac-tivation	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
plate-bound	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
mAbs	NULL
for	NULL
40	NULL
h	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Replacement	NULL
of	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
with	NULL
the	NULL
PV-1	NULL
anti-CD28	NULL
mAb	NULL
,	NULL
which	NULL
differs	NULL
in	NULL
its	NULL
CD28	NULL
epitope	NULL
specificity	NULL
from	NULL
the	NULL
37.51	NULL
mAb	NULL
,	NULL
also	NULL
did	NULL
not	NULL
stimulate	NULL
JNK-1	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
37.51	NULL
anti-CD28	NULL
mAb	NULL
elicited	NULL
full	NULL
JINK-1	NULL
activation	NULL
in	NULL
preactivated	NULL
proliferating	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
a	NULL
solid-phase	NULL
JNK	NULL
assay	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
using	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
of	NULL
JNK-1	NULL
and	NULL
JNK-2	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
JNK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
CD3	NULL
and	NULL
CD28	NULL
ligation	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
anti-JNK	NULL
Abs	NULL
used	NULL
to	NULL
immunoprecipitate	NULL
all	NULL
isoforms	NULL
of	NULL
JNK	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
gel	NULL
loading	NULL
of	NULL
equivalent	NULL
amounts	NULL
of	NULL
JNK	NULL
proteins	NULL
was	NULL
confirmed	NULL
by	NULL
anti-JNK	NULL
immunoblotting	NULL
,	NULL
which	NULL
excludes	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
observations	NULL
result	NULL
from	NULL
unequal	NULL
amounts	NULL
of	NULL
kinase	NULL
proteins	NULL
loaded	NULL
.	NULL

It	NULL
is	NULL
evident	NULL
therefore	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
detect	NULL
JNK	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
CD3/CD28	NULL
coligation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
an	NULL
inappropriate	NULL
anti-CD28	NULL
mAb	NULL
.	NULL

Thus	NULL
,	NULL
JNK	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
mediate	NULL
CD28	NULL
costimulatory	NULL
signaling	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Additional	NULL
supportive	NULL
evidence	NULL
for	NULL
a	NULL
role	NULL
for	NULL
p38	NULL
MAPK	NULL
in	NULL
T	NULL
cell	NULL
costimulation	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
use	NULL
of	NULL
$	NULL
B203580	NULL
,	NULL
a	NULL
highly	NULL
specific	NULL
pyrinidyl	NULL
imidazole	NULL
inhibitor	NULL
of	NULL
p38	NULL
MAPK	NULL
(	NULL
17	NULL
)	NULL
.	NULL

$	NULL
B203580	NULL
effectively	NULL
blocked	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
cytokine	NULL
(	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
)	NULL
production	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
activation	NULL
following	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
lend	NULL
credence	NULL
to	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3828	NULL
idea	NULL
that	NULL
p38	NULL
MAPK	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
TCR/CD28	NULL
costimulation	NULL
of	NULL
proliferation	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

Since	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
cytokine	NULL
secretion	NULL
by	NULL
S	NULL
$	NULL
B203580	NULL
does	NULL
not	NULL
result	NULL
from	NULL
T	NULL
cell	NULL
death	NULL
or	NULL
T	NULL
cell	NULL
toxicity	NULL
,	NULL
$	NULL
B203580	NULL
treatment	NULL
appears	NULL
to	NULL
induce	NULL
the	NULL
functional	NULL
unrespon-siveness	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
latter	NULL
observation	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
p38	NULL
MAPK	NULL
may	NULL
regulate	NULL
the	NULL
entry	NULL
of	NULL
T	NULL
cells	NULL
into	NULL
a	NULL
state	NULL
of	NULL
anergy	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
SB203580	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
anti-CD3-induced	NULL
deletion	NULL
of	NULL
CD4	NULL
*CD8*	NULL
thymocytes	NULL
in	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
complex	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
AP-1	NULL
transcriptional	NULL
activation	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
region	NULL
may	NULL
comprise	NULL
either	NULL
a	NULL
c-Jun-c-Jun	NULL
homodimer	NULL
or	NULL
c-Jun-Fos	NULL
heterodimer	NULL
,	NULL
and	NULL
formation	NULL
of	NULL
the	NULL
AP-1	NULL
complex	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Decreased	NULL
binding	NULL
of	NULL
the	NULL
AP-1	NULL
protein	NULL
complex	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
c-Jun	NULL
at	NULL
Ser	NULL
and	NULL
Ser'*	NULL
activates	NULL
c-Jun	NULL
gene	NULL
transcription	NULL
(	NULL
10	NULL
,	NULL
53	NULL
)	NULL
,	NULL
and	NULL
this	NULL
phosphorylation	NULL
is	NULL
mediated	NULL
by	NULL
JNK	NULL
,	NULL
but	NULL
not	NULL
p38	NULL
MAPK	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CD3/	NULL
CD28	NULL
or	NULL
PMA/Ca**	NULL
ionophore	NULL
costimulation	NULL
did	NULL
not	NULL
result	NULL
in	NULL
appreciable	NULL
JNK-1	NULL
or	NULL
JNK-2	NULL
activation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
;	NULL
rather	NULL
,	NULL
PMA/Ca	NULL
``	NULL
*	NULL
ionophore	NULL
costimulation	NULL
inhibited	NULL
JNK-1	NULL
activity	NULL
in	NULL
these	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
c-Jun	NULL
phosphorylation	NULL
by	NULL
p38	NULL
MAPK	NULL
in	NULL
CD3/CD28-costimulated	NULL
mouse	NULL
thy-mocytes	NULL
,	NULL
c-Jun	NULL
protein	NULL
synthesis	NULL
induced	NULL
by	NULL
CD3	NULL
or	NULL
CD3/CD28	NULL
ligation	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
findings	NULL
,	NULL
SB203580	NULL
is	NULL
known	NULL
to	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
genes	NULL
by	NULL
various	NULL
stimuli	NULL
despite	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
effect	NULL
of	NULL
$	NULL
B203580	NULL
on	NULL
c-Jun	NULL
and	NULL
ATF-2	NULL
phosphorylation	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
by	NULL
p38	NULL
MAPK	NULL
may	NULL
be	NULL
essential	NULL
for	NULL
c-Jun	NULL
gene	NULL
activation	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
ATF-2	NULL
can	NULL
be	NULL
phosphorylated	NULL
by	NULL
p38	NULL
MAPK	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
ATF-2	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

ATF-2	NULL
may	NULL
therefore	NULL
mediate	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
gene	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
monocytes	NULL
that	NULL
migrate	NULL
to	NULL
a	NULL
site	NULL
of	NULL
inflammation	NULL
,	NULL
phosphorylation	NULL
of	NULL
MEF2C	NULL
by	NULL
p38	NULL
MAPK	NULL
increases	NULL
c-Jun	NULL
transcription	NULL
and	NULL
inhibition	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
diminishes	NULL
LPS-induced	NULL
c-Jun	NULL
transcription	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
p38	NULL
MAPK	NULL
may	NULL
be	NULL
the	NULL
major	NULL
kinase	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
activation	NULL
in	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
JNK-3	NULL
has	NULL
been	NULL
identified	NULL
(	NULL
54	NULL
)	NULL
,	NULL
JNK-3	NULL
is	NULL
selectively	NULL
expressed	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
,	NULL
and	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
JNK-3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
phosphorylation	NULL
and	NULL
induction	NULL
of	NULL
c-Jun	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
effect	NULL
of	NULL
$	NULL
B203580	NULL
on	NULL
nuclear	NULL
c-Fos	NULL
expression	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
CD3	NULL
ligation	NULL
also	NULL
activates	NULL
ERK-1	NULL
,	NULL
which	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
$	NULL
B203580	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
p38	NULL
MAPK	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
TCR-	NULL
and	NULL
CD28-signaling	NULL
pathways	NULL
,	NULL
and	NULL
that	NULL
p38	NULL
MAPK	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
primary	NULL
mouse	NULL
T	NULL
cells	NULL
.	NULL

p38	NULL
MAPK	NULL
activity	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-Jun	NULL
activation	NULL
,	NULL
augmentation	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
stimulation	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
production	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
MAPK	NULL
activity	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

S.	NULL
Kaga	NULL
and	NULL
H.	NULL
Tan	NULL
for	NULL
helpful	NULL
discussions	NULL
;	NULL
Drs	NULL
.	NULL

J.	NULL
Bluestone	NULL
,	NULL
J.	NULL
P.	NULL
Allison	NULL
,	NULL
P.	NULL
Young	NULL
,	NULL
and	NULL
C.	NULL
June	NULL
for	NULL
their	NULL
kind	NULL
gifts	NULL
of	NULL
various	NULL
reagents	NULL
that	NULL
made	NULL
this	NULL
work	NULL
possible	NULL
;	NULL
Ms.	NULL
A.	NULL
Leaist	NULL
for	NULL
her	NULL
valuable	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
;	NULL
and	NULL
all	NULL
members	NULL
of	NULL
our	NULL
laboratory	NULL
for	NULL
their	NULL
advice	NULL
and	NULL
encouragement	NULL
.	NULL

COSTIMULATORY	NULL
ACTIVATION	NULL
OF	NULL
p38	NULL
MAPK	NULL
IN	NULL
PRIMARY	NULL
T	NULL
CELLS	NULL
References	NULL
1	NULL
.	NULL

Blenis	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Signal	NULL
transduction	NULL
via	NULL
the	NULL
MAP	NULL
kinases	NULL
:	NULL
proceed	NULL
at	NULL
your	NULL
own	NULL
RSK	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5889	NULL
.	NULL

2	NULL
.	NULL

Cobb	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Goldsmith	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
MAP	NULL
kinases	NULL
are	NULL
regulated	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14843	NULL
.	NULL

3	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

286:14553	NULL
.	NULL

4	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
Avruch	NULL
.	NULL

1996	NULL
.	NULL

Sounding	NULL
the	NULL
alarm	NULL
:	NULL
protein	NULL
kinase	NULL
cascades	NULL
activated	NULL
by	NULL
stress	NULL
and	NULL
inflammation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:24313	NULL
.	NULL

5	NULL
.	NULL

Deacon	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Blank	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
4	NULL
(	NULL
MKK4	NULL
)	NULL
/c-Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
1	NULL
and	NULL
MKK3/p38	NULL
pathways	NULL
regulated	NULL
by	NULL
MEK	NULL
kinases	NULL
2	NULL
and	NULL
3	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:14489	NULL
.	NULL

6	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
L-H.	NULL
Wu	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Independent	NULL
human	NULL
MAP	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
defined	NULL
by	NULL
MEK	NULL
and	NULL
MKK	NULL
isoforms	NULL
.	NULL

Science	NULL
267:682	NULL
.	NULL

7	NULL
.	NULL

Ellinger-Ziegelbauer	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1997	NULL
.	NULL

Direct	NULL
activation	NULL
of	NULL
the	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
and	NULL
extracellular	NULL
signal-regulated	NULL
protein	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
pathways	NULL
by	NULL
an	NULL
inducible	NULL
mitogen-activated	NULL
protein	NULL
kinase/	NULL
ERK	NULL
kinase	NULL
kinase	NULL
3	NULL
(	NULL
MEKK	NULL
)	NULL
derivative	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:2668	NULL
.	NULL

8	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
J.	NULL
Whitmarsh	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1996	NULL
.	NULL

MKK3-	NULL
and	NULL
MKK6-regulated	NULL
gene	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1247	NULL
.	NULL

9	NULL
.	NULL

Tibbles	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Y.	NULL
L.	NULL
Ing	NULL
,	NULL
F.	NULL
Kiefer	NULL
,	NULL
J.	NULL
Chan	NULL
,	NULL
N.	NULL
Iscove	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Lassam	NULL
.	NULL

1996	NULL
.	NULL

MLK-3	NULL
activates	NULL
the	NULL
SAPK/JINK	NULL
and	NULL
p38/RK	NULL
pathways	NULL
via	NULL
SEK1	NULL
and	NULL
MKK3/6	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:7026	NULL
.	NULL

10	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
I.	NULL
H.	NULL
Wu	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76:1025	NULL
.	NULL

11	NULL
.	NULL

Adler	NULL
,	NULL
V.	NULL
,	NULL
M.	NULL
R.	NULL
Pincus	NULL
,	NULL
A.	NULL
Polotskaya	NULL
,	NULL
X.	NULL
Montano	NULL
,	NULL
F.	NULL
K.	NULL
Friedman	NULL
,	NULL
and	NULL
Z.	NULL
Ronai	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
c-Jun-NH-kinase	NULL
by	NULL
UV	NULL
irradiation	NULL
is	NULL
dependent	NULL
on	NULL
p21	NULL
``	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:23304	NULL
.	NULL

12	NULL
.	NULL

Chen	NULL
,	NULL
Y.	NULL
R.	NULL
,	NULL
C.	NULL
F.	NULL
Meyer	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1996	NULL
.	NULL

Persistent	NULL
activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
1	NULL
(	NULL
JNK1	NULL
)	NULL
in	NULL
y	NULL
radiation-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:631	NULL
.	NULL

13	NULL
.	NULL

Galcheva-Gargova	NULL
,	NULL
Z.	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
L-H.	NULL
Wu	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
osmo-sensing	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265:806	NULL
.	NULL

14	NULL
.	NULL

Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
J	NULL
.	NULL

Best	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
-induced	NULL
E-selectin	NULL
expression	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
nuclear	NULL
factor-kB	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase/p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:2753	NULL
.	NULL

15	NULL
.	NULL

Rosette	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Ultraviolet	NULL
light	NULL
and	NULL
osmotic	NULL
stress	NULL
:	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
cascade	NULL
through	NULL
multiple	NULL
growth	NULL
factor	NULL
and	NULL
cytokine	NULL
receptors	NULL
.	NULL

Science	NULL
274:1194	NULL
.	NULL

16	NULL
.	NULL

Swantek	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
M.	NULL
H.	NULL
Cobb	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Geppert	NULL
.	NULL

1997	NULL
.	NULL

Jun	NULL
N-terminal	NULL
kinase/	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
JINK/SAPK	NULL
)	NULL
is	NULL
required	NULL
for	NULL
lipopolysaccharide	NULL
stimulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
translation	NULL
:	NULL
glucocorticoids	NULL
inhibit	NULL
TNF-a	NULL
translation	NULL
by	NULL
blocking	NULL
JNK/SAPK	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:6274	NULL
.	NULL

17	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

Rouse	NULL
,	NULL
Y.	NULL
N.	NULL
Doza	NULL
,	NULL
R.	NULL
Meier	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
T.	NULL
F.	NULL
Gallagher	NULL
,	NULL
P.	NULL
R.	NULL
Young	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lee	NULL
.	NULL

1995	NULL
.	NULL

$	NULL
B203580	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
a	NULL
MAP	NULL
kinase	NULL
homologue	NULL
which	NULL
is	NULL
stimulated	NULL
by	NULL
cellular	NULL
stresses	NULL
and	NULL
interleukin-1	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

364:229	NULL
.	NULL

18	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Gupta	NULL
,	NULL
J.	NULL
S.	NULL
Rogers	NULL
,	NULL
M.	NULL
Dickens	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
ty-rosine	NULL
and	NULL
threonine	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:7420	NULL
.	NULL

19	NULL
.	NULL

Rouse	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
S.	NULL
Trigon	NULL
,	NULL
M.	NULL
Morange	NULL
,	NULL
A.	NULL
Alonso-Liamazares	NULL
,	NULL
D.	NULL
Zamanillo	NULL
,	NULL
T.	NULL
Hunt	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Nebreda	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
that	NULL
stimulates	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Cell	NULL
78:1027	NULL
.	NULL

20	NULL
.	NULL

Yamauchi	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Nagao	NULL
,	NULL
Y.	NULL
Kaziro	NULL
,	NULL
and	NULL
H.	NULL
Itoh	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
by	NULL
signaling	NULL
through	NULL
&	NULL
protein-coupled	NULL
receptors	NULL
:	NULL
involvement	NULL
of	NULL
Gbetagamma	NULL
and	NULL
Galphaq/11	NULL
subunits	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

272:27771	NULL
.	NULL

21	NULL
.	NULL

Cuenda	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
V.	NULL
Buée-Scherrer	NULL
,	NULL
and	NULL
M.	NULL
Goedert	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase-3	NULL
(	NULL
SAPK3	NULL
)	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stresses	NULL
is	NULL
mediated	NULL
via	NULL
SAPKK3	NULL
(	NULL
MKK6	NULL
)	NULL
;	NULL
comparison	NULL
of	NULL
the	NULL
specificities	NULL
of	NULL
SAPK3	NULL
and	NULL
SAPK2	NULL
(	NULL
RK/p38	NULL
)	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:295	NULL
.	NULL

22	NULL
.	NULL

Graves	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
K.	NULL
E.	NULL
Draves	NULL
,	NULL
A.	NULL
Craxton	NULL
,	NULL
J.	NULL
Saklatvala	NULL
,	NULL
E.	NULL
G.	NULL
Krebs	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clark	NULL
.	NULL

1996	NULL
.	NULL

Involvement	NULL
of	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
and	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
in	NULL
mIgM-induced	NULL
apoptosis	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:13814	NULL
.	NULL

23	NULL
.	NULL

Kummer	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
P.	NULL
K.	NULL
Rao	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Heidenreich	NULL
.	NULL

1997	NULL
.	NULL

Apoptosis	NULL
induced	NULL
by	NULL
withdrawal	NULL
of	NULL
trophic	NULL
factors	NULL
is	NULL
mediated	NULL
by	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:20490	NULL
.	NULL

24	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
J.	NULL
T.	NULL
Laydon	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
T.	NULL
F.	NULL
Gallagher	NULL
,	NULL
S.	NULL
Kumar	NULL
,	NULL
D.	NULL
Green	NULL
,	NULL
D.	NULL
McNutty	NULL
,	NULL
M.	NULL
J.	NULL
Blumenthal	NULL
,	NULL
J.	NULL
R.	NULL
Heys	NULL
,	NULL
S.	NULL
W.	NULL
Landvatter	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
372:739	NULL
.	NULL

25	NULL
.	NULL

Price	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
F.	NULL
H.	NULL
Cruzalegui	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
p38	NULL
and	NULL
ERK	NULL
MAP	NULL
kinase	NULL
pathways	NULL
cooperate	NULL
to	NULL
activate	NULL
ternary	NULL
complex	NULL
factors	NULL
and	NULL
c-fos	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
UV	NULL
light	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6552	NULL
.	NULL

26	NULL
.	NULL

Toyoshima	NULL
,	NULL
F.	NULL
,	NULL
T.	NULL
Moriguchi	NULL
,	NULL
and	NULL
E.	NULL
Nishida	NULL
.	NULL

1997	NULL
.	NULL

Fas	NULL
induces	NULL
cytoplasmic	NULL
apoptotic	NULL
responses	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
MKK7-JNK/SAPK	NULL
and	NULL
MKK6-p38	NULL
pathways	NULL
independent	NULL
of	NULL
CPP32-like	NULL
proteases	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

139:1005	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Chen	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
W.	NULL
Guo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gegner	NULL
,	NULL
S.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Han	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
p38	NULL
B	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:17920	NULL
.	NULL

Goedert	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
M.	NULL
Graxton	NULL
,	NULL
R.	NULL
Jakes	NULL
,	NULL
and	NULL
P.	NULL
Cohen	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
novel	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
SAPK4	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stresses	NULL
is	NULL
mediated	NULL
by	NULL
SKK3	NULL
(	NULL
MKK6	NULL
)	NULL
;	NULL
comparison	NULL
of	NULL
its	NULL
substrate	NULL
specificity	NULL
with	NULL
that	NULL
of	NULL
other	NULL
SAP	NULL
kinases	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3563	NULL
.	NULL

Tan	NULL
,	NULL
Y.	NULL
,	NULL
J	NULL
.	NULL

Rouse	NULL
,	NULL
Z.	NULL
Zhang	NULL
,	NULL
S.	NULL
Cariati	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Comb	NULL
.	NULL

1996	NULL
.	NULL

FGF	NULL
and	NULL
stress	NULL
regulate	NULL
CREB	NULL
and	NULL
ATF-1	NULL
via	NULL
pathway	NULL
involving	NULL
RK/p38	NULL
MAP	NULL
kinase	NULL
and	NULL
MAPAP	NULL
kinase-2	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:4629	NULL
.	NULL

Wang	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
D.	NULL
Ron	NULL
.	NULL

1996	NULL
.	NULL

Stress-induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
CHOP	NULL
(	NULL
GADD153	NULL
)	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

Science	NULL
272	NULL
:	NULL
1347	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Y.	NULL
Jiang	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
V.	NULL
V.	NULL
Kravchenko	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEF2C	NULL
by	NULL
the	NULL
MAP	NULL
kinase	NULL
p38	NULL
in	NULL
inflammation	NULL
.	NULL

Nature	NULL
386:296	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
factor	NULL
ATF2	NULL
regulation	NULL
by	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Science	NULL
267:389	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

Li	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
D.	NULL
Whaley	NULL
,	NULL
A.	NULL
Mondino	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1996	NULL
.	NULL

Blocked	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
protein	NULL
kinases	NULL
in	NULL
anergic	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
271:1272	NULL
.	NULL

DeSilva	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
E.	NULL
A.	NULL
Jones	NULL
,	NULL
W.	NULL
S.	NULL
Feeser	NULL
,	NULL
E.	NULL
J.	NULL
Manos	NULL
,	NULL
and	NULL
P.	NULL
Scherle	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
in	NULL
activated	NULL
and	NULL
anergic	NULL
Th1	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

180:116	NULL
.	NULL

Salmon	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
I.	NULL
N.	NULL
Foltz	NULL
,	NULL
P.	NULL
R.	NULL
Young	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Schrader	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
is	NULL
activated	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
T	NULL
or	NULL
B	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
,	NULL
Fas	NULL
or	NULL
CD40	NULL
,	NULL
but	NULL
suppression	NULL
of	NULL
kinase	NULL
activity	NULL
does	NULL
not	NULL
inhibit	NULL
apoptosis	NULL
induced	NULL
by	NULL
antigen	NULL
receptors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5309	NULL
.	NULL

Nishina	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Bachmann	NULL
,	NULL
A.	NULL
J.	NULL
Oliveira-dos-Santos	NULL
,	NULL
L	NULL
Kozieradzki	NULL
,	NULL
K.	NULL
D.	NULL
Fischer	NULL
,	NULL
B.	NULL
Odermait	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
A.	NULL
Shahinian	NULL
,	NULL
H.	NULL
Takimoto	NULL
,	NULL
A.	NULL
Bernstein	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Impaired	NULL
CD28-mediated	NULL
interleukin-2	NULL
production	NULL
and	NULL
proliferation	NULL
in	NULL
stress	NULL
kinase	NULL
SAPK/ERK1	NULL
kinase	NULL
(	NULL
SEK	NULL
1	NULL
)	NULL
/mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
4	NULL
(	NULL
MKK4	NULL
)	NULL
-deficient	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:941	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
R.	NULL
V.	NULL
Parry	NULL
,	NULL
J.	NULL
Matthews	NULL
,	NULL
and	NULL
L.	NULL
O'Neill	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
p38	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
$	NULL
B203580	NULL
inhibits	NULL
CD28-dependent	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

25:3048	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Li	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
A.	NULL
Minden	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2135	NULL
.	NULL

Dolmetsch	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
R.	NULL
S.	NULL
Lewis	NULL
,	NULL
C.	NULL
C.	NULL
Goodnow	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Healy	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
induced	NULL
by	NULL
Ca**	NULL
response	NULL
amplitude	NULL
and	NULL
du-ration	NULL
.	NULL

Nature	NULL
386:855	NULL
.	NULL

Kalluni	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
I.	NULL
Tsigelny	NULL
,	NULL
H.	NULL
K.	NULL
Sluss	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
G.	NULL
Moore	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1994	NULL
.	NULL

JNK2	NULL
contains	NULL
a	NULL
specificity-determining	NULL
region	NULL
responsible	NULL
for	NULL
efficient	NULL
c-Jun	NULL
binding	NULL
and	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2996	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

3829	NULL
Sluss	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
mediated	NULL
by	NULL
JNK	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
8376	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
A.	NULL
J.	NULL
Whitarsh	NULL
,	NULL
J.	NULL
Cavanagh	NULL
,	NULL
H.	NULL
K.	NULL
Sluss	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1996	NULL
.	NULL

Selective	NULL
interaction	NULL
of	NULL
JNK	NULL
protein	NULL
kinase	NULL
isoforms	NULL
with	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2760	NULL
.	NULL

Whitmarsh	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
S.-H.	NULL
Yang	NULL
,	NULL
M.	NULL
S.-S.	NULL
Su	NULL
,	NULL
A.	NULL
D.	NULL
Sharrocks	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
p38	NULL
and	NULL
JNK	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
ternary	NULL
complex	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2360	NULL
.	NULL

Hazzalin	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
E.	NULL
Cano	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
M.	NULL
J.	NULL
Barratt	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Mahadevan	NULL
.	NULL

1996.	NULL
p38/RK	NULL
is	NULL
essential	NULL
for	NULL
stress-induced	NULL
nuclear	NULL
response	NULL
:	NULL
JNK/SAPKs	NULL
and	NULL
c-Jun/ATF-2	NULL
phosphorylation	NULL
are	NULL
insufficient	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

6:1028	NULL
.	NULL

Hazzalin	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
E.	NULL
Cano	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Mahadevan	NULL
.	NULL

1997	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
p38/RK	NULL
MAP	NULL
kinase	NULL
on	NULL
induction	NULL
of	NULL
five	NULL
fos	NULL
and	NULL
jun	NULL
genes	NULL
by	NULL
diverse	NULL
stimuli	NULL
.	NULL

Oncogene	NULL
15:2321	NULL
.	NULL

Yang	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Tournier	NULL
,	NULL
M.	NULL
Wysk	NULL
,	NULL
H.-T.	NULL
Lu	NULL
,	NULL
J.	NULL
Xu	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
MKK4	NULL
gene	NULL
causes	NULL
embryonic	NULL
death	NULL
,	NULL
inhibition	NULL
of	NULL
c-Jun	NULL
NH2-terminal	NULL
kinase	NULL
activation	NULL
,	NULL
and	NULL
defects	NULL
in	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:3004	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Enslen	NULL
,	NULL
J.	NULL
Raingeaud	NULL
,	NULL
M.	NULL
Recht	NULL
,	NULL
T.	NULL
Zapton	NULL
,	NULL
M.	NULL
S.-S.	NULL
Su	NULL
,	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1998	NULL
.	NULL

Interferon-y	NULL
expression	NULL
by	NULL
Th1	NULL
effector	NULL
T	NULL
cells	NULL
mediated	NULL
by	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:2817	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
Bochme	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
B.	NULL
Combadiere	NULL
,	NULL
G.	NULL
Fisher	NULL
,	NULL
M.	NULL
Freedman	NULL
,	NULL
H.	NULL
McFarland	NULL
,	NULL
C.	NULL
Pelfrey	NULL
,	NULL
and	NULL
L.	NULL
Zheng	NULL
.	NULL

1995	NULL
.	NULL

Autocrine	NULL
feedback	NULL
death	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
mature	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
responses	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:115	NULL
.	NULL

Calvo	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Kruisbeck	NULL
.	NULL

1997	NULL
.	NULL

Cytotoxic	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
4	NULL
(	NULL
CTLA-4	NULL
)	NULL
interferes	NULL
with	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
and	NULL
Jun	NULL
NH	NULL
,	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
activation	NULL
,	NULL
but	NULL
does	NULL
not	NULL
affect	NULL
phosphorylation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
£	NULL
and	NULL
ZAP-70	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1645	NULL
.	NULL

Sugawara	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Moriguchi	NULL
,	NULL
E.	NULL
Nishida	NULL
,	NULL
and	NULL
Y.	NULL
Takahama	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
roles	NULL
of	NULL
ERK	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
pathways	NULL
in	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
9:565	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
K.	NULL
Brorson	NULL
,	NULL
R.	NULL
H.	NULL
Schwartz	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
by	NULL
AP-1	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
.	NULL

Science	NULL
257:1134	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Lin	NULL
,	NULL
F.	NULL
X.	NULL
Claret	NULL
,	NULL
A.	NULL
Abo	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Selective	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
signaling	NULL
cascade	NULL
and	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
by	NULL
the	NULL
small	NULL
GTPases	NULL
Rac	NULL
and	NULL
Cdc42Hs	NULL
.	NULL

Cell	NULL
81:1147	NULL
.	NULL

Yang	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
C.	NULL
Y.	NULL
Kuan	NULL
,	NULL
A.	NULL
J.	NULL
Whitmarsh	NULL
,	NULL
M.	NULL
Rincon	NULL
,	NULL
T.	NULL
S.	NULL
Zheng	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
P.	NULL
Rakic	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

Absence	NULL
of	NULL
excitotoxicity-induced	NULL
apoptosis	NULL
in	NULL
the	NULL
hippocampus	NULL
of	NULL
mice	NULL
lacking	NULL
the	NULL
Jnk	NULL
gene	NULL
.	NULL

Nature	NULL
389:865	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

